Research Article
R C Bargou, F Emmerich, D Krappmann, K Bommert, M Y Mapara, W Arnold, H D Royer, E Grinstein, A Greiner, C Scheidereit, B Dörken
Title and authors | Publication | Year |
---|---|---|
Integrative bioinformatics and machine learning identify key crosstalk genes and immune interactions in head and neck cancer and Hodgkin lymphoma.
Qin M, Li X, Gong X, Hu Y, Tang M |
Scientific reports | 2025 |
Immune Deficiency/Dysregulation-Associated EBV-Positive Classic Hodgkin Lymphoma.
Alibrahim MN, Gloghini A, Carbone A |
Cancers | 2025 |
Expression Patterns of GATA3 in Classical Hodgkin Lymphoma: A Clinico-Pathological Study
Papoudou-Bai A, Koumpis E, Karpathiou G, Hatzimichael E, Kanavaros P |
Diseases | 2024 |
Research landmarks on the 60th anniversary of Epstein-Barr virus.
Zhong LY, Xie C, Zhang LL, Yang YL, Liu YT, Zhao GX, Bu GL, Tian XS, Jiang ZY, Yuan BY, Li PL, Wu PH, Jia WH, Münz C, Gewurz BE, Zhong Q, Sun C, Zeng MS |
Science China. Life sciences | 2024 |
3D-Q-FISH/Telomere/TRF2 Nanotechnology Identifies a Progressively Disturbed Telomere/Shelterin/Lamin AC Complex as the Common Pathogenic, Molecular/Spatial Denominator of Classical Hodgkin Lymphoma
Knecht H, Petrogiannis-Haliotis T, Louis S, Mai S |
Cells | 2024 |
Exploring mechanisms of skin aging: insights for clinical treatment
Zhang M, Lin Y, Han Z, Huang X, Zhou S, Wang S, Zhou Y, Han X, Chen H |
Frontiers in Immunology | 2024 |
New molecular targets in Hodgkin and Reed-Sternberg cells
Sadaf H, Ambroziak M, Binkowski R, Kluebsoongnoen J, Paszkiewicz-Kozik E, Steciuk J, Markowicz S, Walewski J, Sarnowska E, Sarnowski TJ, Konopinski R |
Frontiers in immunology | 2023 |
Identification and Interpretation of eQTL and eGenes for Hodgkin Lymphoma Susceptibility.
An Y, Lee C |
Genes & development | 2023 |
The Association of Epstein-Barr Virus With Cancer
Patel PD, Alghareeb R, Hussain A, Maheshwari MV, Khalid N |
Cureus | 2022 |
MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells.
Maharati A, Zanguei AS, Khalili-Tanha G, Moghbeli M |
Cell communication and signaling : CCS | 2022 |
An Update on the Pathology and Molecular Features of Hodgkin Lymphoma.
Satou A, Takahara T, Nakamura S |
Cancers | 2022 |
Impact of Tumour Epstein-Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL.
Nohtani M, Vrzalikova K, Ibrahim M, Powell JE, Fennell É, Morgan S, Grundy R, McCarthy K, Dewberry S, Bouchal J, Bouchalova K, Kearns P, Murray PG |
Cancers | 2022 |
CTRP1 Knockout Attenuates Tumor Progression in A549 and HCT116 Cancer Cells.
Park R, Park YI, Park Y, Lee S, So J, Park J |
Cancers | 2022 |
NFkB Pathway and Hodgkin Lymphoma.
Jardin F |
Biomedicines | 2022 |
EBV-associated diseases: Current therapeutics and emerging technologies
Chakravorty S, Afzali B, Kazemian M |
Frontiers in immunology | 2022 |
Impaired Heat Shock Protein Expression in Activated T Cells in B-Cell Lymphoma.
Albakova Z, Mangasarova Y, Sapozhnikov A |
Biomedicines | 2022 |
Heat Shock Proteins in Lymphoma Immunotherapy
Z Albakova, Y Mangasarova, A Sapozhnikov |
Frontiers in immunology | 2021 |
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
X Cui, CM Snapper |
Frontiers in immunology | 2021 |
Molecular biology of Hodgkin lymphoma
MA Weniger, R Küppers |
Leukemia | 2021 |
Handbook of Research on Advancements in Cancer Therapeutics:
S Kumar, MA Rizvi, S Verma |
2021 | |
Xanthoangelol modulates Caspase-1-dependent pyroptotic death among hepatocellular carcinoma cells with high expression of GSDMD
X Pang, X Gao, F Liu, Y Jiang, M Wang, Q Li, Z Li |
Journal of Functional Foods | 2021 |
The Nonstructural Protein NSs of Severe Fever with Thrombocytopenia Syndrome Virus Causes a Cytokine Storm through the Hyperactivation of NF- κ B
J Khalil, S Yamada, Y Tsukamoto, H Abe, M Shimojima, H Kato, T Fujita |
Molecular and cellular biology | 2021 |
Anti-cancer effect of metformin on the metastasis and invasion of primary breast cancer cells through mediating NF-kB activity
G Yenmis, EY Sarac, N Besli, T Soydas, C Tastan, DD Kancagi, M Yilanci, K Senol, OO Karagulle, CG Ekmekci, E Ovali, M Tuncdemir, T Ulutin, GK Sultuybek |
Acta Histochemica | 2021 |
Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia
C Schleiss, R Carapito, LM Fornecker, L Muller, N Paul, O Tahar, A Pichot, M Tavian, A Nicolae, L Miguet, L Mauvieux, R Herbrecht, S Cianferani, JN Freund, C Carapito, M Maumy-Bertrand, S Bahram, F Bertrand, L Vallat |
Leukemia | 2021 |
Ultraviolet Radiation and Basal Cell Carcinoma: An Environmental Perspective
Y Teng, Y Yu, S Li, Y Huang, D Xu, X Tao, Y Fan |
Frontiers in public health | 2021 |
MicroRNA and Other Non-Coding RNAs in Epstein–Barr Virus-Associated Cancers
KI Notarte, S Senanayake, I Macaranas, PM Albano, L Mundo, E Fennell, L Leoncini, P Murray |
Cancers | 2021 |
AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL
Z Wu, M Nicoll, RJ Ingham |
Experimental Hematology and Oncology | 2021 |
Hodgkin Lymphoma: A Comprehensive Overview
A Engert, A Younes |
2020 | |
Phenolic and glycidic profiling of bananas Musa sp associated with maturation stage and cancer chemoprevention activities
BG Oliveira, EF Pimentel, AC Pereira, F Tosato, FE Pinto, JA Ventura, DC Endringer, W Romão |
Microchemical Journal | 2020 |
Glossogyne tenuifolia Attenuates Proliferation and Migration of Vascular Smooth Muscle Cells
CF Hsuan, YC Lu, IT Tsai, JY Houng, SW Wang, TH Chang, YL Chen, CC Chang |
Molecules (Basel, Switzerland) | 2020 |
Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future
M Bienz, S Ramdani, H Knecht |
International journal of molecular sciences | 2020 |
An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma
PG Murray, LS Young |
Blood | 2019 |
Evidence that TNF-β induces proliferation in colorectal cancer cells and resveratrol can down-modulate it
C Buhrmann, M Yazdi, B Popper, P Shayan, A Goel, BB Aggarwal, M Shakibaei |
Experimental biology and medicine (Maywood, N.J.) | 2019 |
miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1
J Zhou, Y Zhang, Z Han, Z Dong, T Cao, A Wei, P Guo, Q Meng |
Cell cycle (Georgetown, Tex.) | 2019 |
Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma
L von Hoff, E Kärgel, V Franke, E McShane, KW Schulz-Beiss, G Patone, N Schleussner, M Kolesnichenko, N Hübner, O Daumke, M Selbach, A Akalin, S Mathas, C Scheidereit |
Blood | 2019 |
A Comprehensive Review on Pronephrium penangianum
Q Zhou, Y Jian, P Yi, J Sun, X Zhou, S Chen, W Wang |
Israel Journal of Chemistry | 2019 |
Jietacins, azoxy natural products, as novel NF-κB inhibitors: Discovery, synthesis, biological activity, and mode of action
M Watanabe, A Sugawara, Y Noguchi, T Hirose, S Ōmura, T Sunazuka, R Horie |
European Journal of Medicinal Chemistry | 2019 |
Novel Therapeutics for Rare Lymphomas
C Dittus |
2019 | |
Expression of A New Endogenous Retrovirus-Associated Transcript in Hodgkin Lymphoma Cells
J Schneider, I Volkmer, K Engel, A Emmer, MS Staege |
International journal of molecular sciences | 2019 |
Grass carp (Ctenopharyngodon idella) Bcl-xl: transcriptional regulation and anti-apoptosis analysis
G Qi, N Yu, K Xu, X Xie, Y Mao, X Chen, X Ran, X Chen, G Lin, C Hu |
Fish Physiology and Biochemistry | 2019 |
Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
K Vrzalikova, M Ibrahim, E Nagy, M Vockerodt, T Perry, W Wei, C Woodman, P Murray |
Cancers | 2018 |
NF-kappaB: Two Sides of the Same Coin
B Pires, R Silva, G Ferreira, E Abdelhay |
Genes & development | 2018 |
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
V Spina, A Bruscaggin, A Cuccaro, M Martini, MD Trani, G Forestieri, M Manzoni, A Condoluci, A Arribas, L Terzi-Di-Bergamo, SL Locatelli, E Cupelli, L Ceriani, AA Moccia, A Stathis, L Nassi, C Deambrogi, F Diop, F Guidetti, A Cocomazzi, S Annunziata, V Rufini, A Giordano, A Neri, R Boldorini, B Gerber, F Bertoni, M Ghielmini, G Stüssi, A Santoro, F Cavalli, E Zucca, LM Larocca, G Gaidano, S Hohaus, C Carlo-Stella, D Rossi |
Blood | 2018 |
Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives
C Cuceu, W Hempel, L Sabatier, J Bosq, P Carde, R Mkacher |
Cancers | 2018 |
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?
A Carbone, A Gloghini, C Carlo-Stella |
Blood | 2018 |
The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
N Meti, K Esfahani, N Johnson |
Cancers | 2018 |
The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas
IG de los Fayos Alonso, HC Liang, S Turner, S Lagger, O Merkel, L Kenner |
Cancers | 2018 |
The Interplay among PINK1/PARKIN/Dj-1 Network during Mitochondrial Quality Control in Cancer Biology: Protein Interaction Analysis
C Salazar, P Ruiz-Hincapie, L Ruiz |
Cells | 2018 |
The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G1
J Zhang, Z Wu, A Savin, M Yang, YH Hsu, E Jantuan, JT Bacani, RJ Ingham |
Scientific Reports | 2018 |
The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma
D Vrábel, L Pour, S Ševčíková |
Blood Reviews | 2018 |
TNFα promotes proliferation of human synovial MSCs while maintaining chondrogenic potential
M Shioda, T Muneta, K Tsuji, M Mizuno, K Komori, H Koga, I Sekiya, WJ Li |
PloS one | 2017 |
NF-κB in Hematological Malignancies
Imbert V, Peyron JF |
Biomedicines | 2017 |
miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling
S Wang, L Feng, B Hu, Y Lu, W Wang, W Guo, C Suen, B Jiao, J Pang, W Fu, J Zhang |
Molecular Therapy - Nucleic Acids | 2017 |
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies
T Karantanos, I Politikos, V Boussiotis |
Blood and Lymphatic Cancer: Targets and Therapy | 2017 |
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
A Sud, H Thomsen, PJ Law, A Försti, MI da Filho, A Holroyd, P Broderick, G Orlando, O Lenive, L Wright, R Cooke, D Easton, P Pharoah, A Dunning, J Peto, F Canzian, R Eeles, ZS Kote-Jarai, K Muir, N Pashayan, P Hoffmann, MM Nöthen, KH Jöckel, EP von Strandmann, T Lightfoot, E Kane, E Roman, A Lake, D Montgomery, RF Jarrett, AJ Swerdlow, A Engert, N Orr, K Hemminki, RS Houlston |
Nature Communications | 2017 |
Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1
T Szatmári, F Mundt, A Kumar-Singh, L Möbus, R Ötvös, A Hjerpe, K Dobra |
BMC cell biology | 2017 |
Targeting Oncogenic NF-κB Signaling with Redox-Active Agents for Cancer Treatment
L Fouani, Z Kovacevic, DR Richardson |
Antioxidants & Redox Signaling | 2017 |
Precision Molecular Pathology of Hodgkin Lymphoma
SD Hudnall, R Küppers |
Precision Molecular Pathology of Hodgkin Lymphoma | 2017 |
CD30 + Lymphoproliferative Disorders of the Skin
MB Sauder, JT O'Malley, NR LeBoeuf |
Hematology/Oncology Clinics of North America | 2017 |
Brentuximab vedotin: clinical updates and practical guidance
JH Yi, SJ Kim, WS Kim |
Blood Research | 2017 |
Rumex dentatus Inhibits Cell Proliferation, Arrests Cell Cycle, and Induces Apoptosis in MDA-MB-231 Cells through Suppression of the NF-κB Pathway
R Batool, E Aziz, BK Tan, T Mahmood |
Frontiers in pharmacology | 2017 |
The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells
K Huang, C Yang, Q Wang, Y Li, C Fang, Y Tan, J Wei, Y Wang, X Li, J Zhou, B Zhou, K Yi, K Zhang, J Li, C Kang |
Cancer Letters | 2017 |
Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma
M Szydłowski, M Prochorec-Sobieszek, A Szumera-Ciećkiewicz, E Derezińska, G Hoser, D Wasilewska, O Szymańska-Giemza, E Jabłońska, E Białopiotrowicz, T Sewastianik, A Polak, W Czardybon, M Gałęzowski, R Windak, JM Zaucha, K Warzocha, K Brzózka, P Juszczyński |
Blood | 2017 |
Co-Occurrence of Acromegaly and Hematological Disorders: A Myth or Common Pathogenic Mechanism
P Gupta, P Dutta |
Integrative Medicine International | 2017 |
Neoplastic Diseases of the Blood
PH Wiernik, JP Dutcher, MA Gertz |
2017 | |
Rewired NFκB signaling as a potentially actionable feature of activated B-cell-like diffuse large B-cell lymphoma
G Knittel, P Liedgens, D Korovkina, CP Pallasch, HC Reinhardt |
European Journal of Haematology | 2016 |
Mechanisms of NF-κB deregulation in lymphoid malignancies
D Krappmann, M Vincendeau |
Seminars in Cancer Biology | 2016 |
Basal autophagy is pivotal for Hodgkin and Reed-Sternberg cells’ survival and growth revealing a new strategy for Hodgkin lymphoma treatment
K Birkenmeier, K Moll, S Newrzela, S Hartmann, S Dröse, ML Hansmann |
Oncotarget | 2016 |
WNT5A: a motility-promoting factor in Hodgkin lymphoma
F Linke, S Zaunig, MM Nietert, F Bonin, S Lutz, C Dullin, P Janovská, T Beissbarth, F Alves, W Klapper, V Bryja, T Pukrop, L Trümper, J Wilting, D Kube |
Oncogene | 2016 |
Hodgkin lymphoma: Pathology and biology
S Mathas, S Hartmann, R Küppers |
Seminars in Hematology | 2016 |
NF-κB deregulation in Hodgkin lymphoma
MA Weniger, R Küppers |
Seminars in Cancer Biology | 2016 |
Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma
KD Wurster, F Hummel, J Richter, M Giefing, S Hartmann, ML Hansmann, S Kreher, K Köchert, D Krappmann, W Klapper, M Hummel, SS Wenzel, G Lenz, M Janz, B Dörken, R Siebert, S Mathas |
Leukemia | 2016 |
Notch signaling: its roles and therapeutic potential in hematological malignancies
Y Gu, M Masiero, AH Banham |
Oncotarget | 2016 |
Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program: LOCK ET AL
R Lock, H Carol, JM Maris, EA Kolb, R Gorlick, CP Reynolds, MH Kang, ST Keir, J Wu, A Purmal, A Gudkov, D Kurmashev, RT Kurmasheva, PJ Houghton, MA Smith |
Pediatric Blood & Cancer | 2016 |
A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses
KA de Oliveira, E Kaergel, M Heinig, JF Fontaine, G Patone, EM Muro, S Mathas, M Hummel, MA Andrade-Navarro, N Hübner, C Scheidereit |
Genome Medicine | 2016 |
Relevance of the Measles Virus Expression in Cancer - an Update
D Benharroch, S Ariad, N Tadmor, K Nalbandyan, I Lazarev |
Pathology & Oncology Research | 2016 |
CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin Lymphoma Cells
M Watanabe, K Nakano, ME Kadin, M Higashihara, T Watanabe, R Horie |
The American Journal of Pathology | 2016 |
Disease-specific protein complex detection in the human protein interaction network with a supervised learning method
Z Zhou, Y Gui, Z Yang, X Liu, L Wang, Y Zhang, H Lin, J Wang |
2016 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) | 2016 |
Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma
D Ravi, A Beheshti, N Abermil, F Passero, J Sharma, M Coyle, A Kritharis, I Kandela, L Hlatky, MV Sitkovsky, A Mazar, RB Gartenhaus, AM Evens |
Cancer research | 2016 |
Levels of circulating soluble receptor activator of NF-κB and interleukins-1 predicting outcome of locally advanced basal cell carcinoma
Q Lin, Y Li, D Zhang, H Jin |
International journal of immunopathology and pharmacology | 2016 |
Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway
W Sun, L Guo, G Shao, X Liu, Y Guan, L Su, S Zhao |
Oncology reports | 2016 |
Protein phosphatase 1γ regulates the proliferation of human glioma via the NF-κB pathway
Z Bao, C Duan, C Gong, L Wang, C Shen, C Wang, G Cui |
Oncology reports | 2016 |
Molecular Mechanisms in the Pathogenesis of Idiopathic Nephrotic Syndrome
K Kaneko |
2016 | |
[Expression of CD137 in tumor cells of Hodgkin lymphoma from Northern China and its application in pathological differential diagnosis].
Shi YF, Gao ZF, Liu CL, Huang X, Song YQ, Zhang C, Lin DM, Zhou LX, Zhao M, Lai YM, Li M |
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 2016 |
NF-κB in cancer therapy
F Li, J Zhang, F Arfuso, A Chinnathambi, ME Zayed, SA Alharbi, AP Kumar, KS Ahn, G Sethi |
Archives of Toxicology | 2015 |
Epstein Barr Virus Volume 1: One Herpes Virus: Many Diseases
C Münz |
Epstein Barr Virus Volume 1 | 2015 |
Epstein Barr Virus Volume 1: One Herpes Virus: Many Diseases
C Münz |
Epstein Barr Virus Volume 1 | 2015 |
Epstein Barr Virus Volume 1: One Herpes Virus: Many Diseases
C Münz |
Epstein Barr Virus Volume 1 | 2015 |
Lymphomagenesis in Hodgkin lymphoma
E Matsuki, A Younes |
Seminars in Cancer Biology | 2015 |
The Link between Autoimmunity and Lymphoma: Does NOTCH Signaling Play a Contributing Role?
CA Kuksin, LM Minter |
Frontiers in Oncology | 2015 |
A critical assessment of the methodologies to investigate the role of inhibition of apoptosis in rodent hepatocarcinogenesis
R Sura, RS Settivari, MJ LeBaron, JC Rowlands, EW Carney, BB Gollapudi |
Toxicology Mechanisms and Methods | 2015 |
Tumor suppressor genes are larger than apoptosis-effector genes and have more regions of active chromatin: Connection to a stochastic paradigm for sequential gene expression programs
M Garcia, JA Mauro, M Ramsamooj, G Blanck |
Cell cycle (Georgetown, Tex.) | 2015 |
Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis
G Malaponte, SS Signorelli, V Bevelacqua, J Polesel, M Taborelli, C Guarneri, C Fenga, K Umezawa, M Libra, Y St-Pierre |
PloS one | 2015 |
Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation
SA Watt, KJ Purdie, NY Breems, M Dimon, ST Arron, A McHugh, DJ Xue, JH Dayal, CM Proby, CA Harwood, IM Leigh, AP South |
The American Journal of Pathology | 2015 |
S-nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma
K Kaliyaperumal, AK Sharma, DG McDonald, JS Dhindsa, C Yount, AK Singh, JS Won, I Singh |
Redox Biology | 2015 |
Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 1)
MK Pandey, BB Aggarwal |
Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 1) | 2015 |
Regulation of signal transduction by spatial parameters: a case in NF–κB oscillation
H Sagara, D Ohshima, K Ichikawa |
IET Systems Biology | 2015 |
Romo1 and the NF‑κB pathway are involved in oxidative stress‑induced tumor cell invasion
S Lee, Y Park, J Chung, Y Yoo |
International journal of oncology | 2015 |
Protein Modifications in Pathogenic Dysregulation of Signaling
J Inoue, M Takekawa |
2015 | |
Regulation of signal transduction by spatial parameters: a case in NF-κB oscillation.
Ichikawa K, Ohshima D, Sagara H |
IET Systems Biology | 2015 |
Melatonin as a proteasome inhibitor. Is there any clinical evidence?
J Vriend, RJ Reiter |
Life Sciences | 2014 |
NF-κB-induced KIAA1199 promotes survival through EGFR signalling
K Shostak, X Zhang, P Hubert, SI Göktuna, Z Jiang, I Klevernic, J Hildebrand, P Roncarati, B Hennuy, A Ladang, J Somja, A Gothot, P Close, P Delvenne, A Chariot |
Nature Communications | 2014 |
The Epstein-Barr virus and the pathogenesis of lymphoma: EBV and lymphomas
M Vockerodt, LF Yap, C Shannon-Lowe, H Curley, W Wei, K Vrzalikova, PG Murray |
The Journal of Pathology | 2014 |
Investigation of NF-κB1 and NF-κBIA Gene Polymorphism in Non-Small Cell Lung Cancer
YM Oltulu, E Coskunpinar, G Ozkan, E Aynaci, P Yildiz, T Isbir, I Yaylim |
BioMed Research International | 2014 |
Epstein–Barr virus, the germinal centre and the development of Hodgkin’s lymphoma
G Mohamed, K Vrzalikova, FZ Cader, M Vockerodt, E Nagy, P Flodr, LF Yap, A Diepstra, PM Kluin, S Rosati, P Murray |
Journal of General Virology | 2014 |
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
A Munshi, V Sharma |
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis | 2014 |
Does the Measles Virus Contribute to Carcinogenesis? - A Review
D Benharroch, J Gopas, S Ariad |
Journal of Cancer | 2014 |
Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker
Y Yang, NL Rhodus, FG Ondrey, BR Wuertz, X Chen, Y Zhu, TJ Griffin |
PloS one | 2014 |
Human Herpesviruses HHV-6A, HHV-6B & HHV-7
D Vincent, M Tohyama, Y Kano, T Shiohara |
Human Herpesviruses HHV-6A, HHV-6B & HHV-7 | 2014 |
Circulating tumor cells in Hodgkin's lymphoma—A review of the spread of HL tumor cells or their putative precursors by lymphatic and hematogenous means, and their prognostic significance
R Gharbaran, J Park, C Kim, A Goy, KS Suh |
Critical Reviews in Oncology/Hematology | 2014 |
Reed Sternberg cell-derived lymphotoxin-α activates endothelial cells to enhance T cell recruitment in classical Hodgkin lymphoma
Chee Wai Fhu, Anne M Graham, Celestial T Yap, Suhail Al-Salam, Antonio Castella, Siew Meng Chong, Yaw-Chyn Lim |
Blood | 2014 |
FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma
MJ Vogel, L Xie, H Guan, RM Tooze, T Maier, U Kostezka, HJ Maier, K Holzmann, FC Chan, C Steidl, JB Reichel, CD Weitzer, F Gehringer, AB Kick, E Cesarman, M Roshal, RD Gascoyne, P Moller, T Wirth, A Ushmorov |
Blood | 2014 |
Dimethyl fumarate induces apoptosis of hematopoietic tumor cells via inhibition of NF-κB nuclear translocation and down-regulation of Bcl-xL and XIAP
M Tsubaki, N Ogawa, T Takeda, K Sakamoto, H Shimaoka, A Fujita, T Itoh, M Imano, T Satou, S Nishida |
Biomedicine & Pharmacotherapy | 2014 |
Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation
IY Kim, YY He |
Genes & Diseases | 2014 |
Zerumbone Inhibits Angiogenesis by Blocking NF-κB Activity in Pancreatic Cancer:
T Shamoto, Y Matsuo, T Shibata, K Tsuboi, T Nagasaki, H Takahashi, H Funahashi, Y Okada, H Takeyama |
Pancreas | 2014 |
Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies
D Nagel, M Vincendeau, AC Eitelhuber, D Krappmann |
Oncogene | 2014 |
Reflux composition influences the level of NF-κB activation and upstream kinase preference in oesophageal adenocarcinoma cells: NF-κB Activation and Upstream Kinase Preference
E McAdam, HN Haboubi, AP Griffiths, JN Baxter, S Spencer-Harty, C Davies, GJ Jenkins |
International Journal of Cancer | 2014 |
Epstein-Barr virus and the origin of Hodgkin lymphoma
M Vockerodt, FZ Cader, C Shannon-Lowe, P Murray |
Chinese journal of cancer | 2014 |
Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy
A Rosenberg, H Fan, YG Chiu, R Bolce, D Tabechian, R Barrett, S Moorehead, F Baribaud, H Liu, N Peffer, D Shealy, EM Schwarz, CT Ritchlin, P Proost |
PloS one | 2014 |
Nuclear Factor κB–Dependent Regulation of Angiogenesis, and Metastasis in an In Vivo Model of Thyroid Cancer Is Associated With Secreted Interleukin-8
KT Bauerle, RE Schweppe, G Lund, G Kotnis, G Deep, R Agarwal, N Pozdeyev, WM Wood, BR Haugen |
The Journal of clinical endocrinology and metabolism | 2014 |
Obesity and cancer: at the crossroads of cellular metabolism and proliferation
RW O’Rourke |
Surgery for Obesity and Related Diseases | 2014 |
Constitutive NF-κB activation and tumor-growth promotion by Romo1-mediated reactive oxygen species production
JS Chung, S Lee, YD Yoo |
Biochemical and Biophysical Research Communications | 2014 |
Epstein-Barr virus, the germinal centre and the development of Hodgkin's lymphoma
G Mohamed, K Vrzalikova, FZ Cader, M Vockerodt, E Nagy, P Flodr, LF Yap, A Diepstra, PM Kluin, S Rosati, P Murray |
Journal of General Virology | 2014 |
The Gβ5 protein regulates sensitivity to TRAIL-induced cell death in colon carcinoma
D Fuchs, M Metzig, M Bickeböller, C Brandel, W Roth |
Oncogene | 2014 |
The EF-hand calcium-binding protein tescalcin is a potential oncotarget in colorectal cancer
YH Kang, SR Han, JT Kim, SJ Lee, YI Yeom, JK Min, CH Lee, JW Kim, SR Yoon, DY Yoon, KS Hong, GS Hwang, HC Kim, YH Lee, HG Lee |
Oncotarget | 2014 |
Curcumin-based IKKβ inhibiting anticancer lead design using novel fragment-based group QSAR modelling
K Patel, C Tyagi, S Goyal, JK Dhanjal, N Bharadvaja, A Grover |
Medicinal Chemistry Research | 2014 |
The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma
Yukiyo Tada, Shoichiro Kokabu, Goro Sugiyama, Chihiro Nakatomi, Kazuhiro Aoki, Hidefumi Fukushima, Kenji Osawa, Yasutaka Sugamori, Keiichi Ohya, Masato Okamoto, Tomoyuki Fujikawa, Akiko Itai, Kou Matsuo, Seiji Watanabe, Eijiro Jimi |
Oncotarget | 2014 |
Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines
K Harada, T Ferdous, H Kobayashi, Y Ueyama |
International journal of oncology | 2014 |
Hodgkin Lymphoma
A Engert, A Younes |
2014 | |
The Gβ5 protein regulates sensitivity to TRAIL-induced cell death in colon carcinoma.
Fuchs D, Metzig M, Bickeböller M, Brandel C, Roth W |
Oncogene | 2014 |
Antioxidant Function of Isoflavone and 3,3′-Diindolylmethane: Are They Important for Cancer Prevention and Therapy?
Y Li, D Kong, A Ahmad, B Bao, FH Sarkar |
Antioxidants & Redox Signaling | 2013 |
Expression and functional relevance of cannabinoid receptor 1 in hodgkin lymphoma
AH Benz, C Renné, E Maronde, M Koch, U Grabiec, S Kallendrusch, B Rengstl, S Newrzela, S Hartmann, ML Hansmann, F Dehghani |
PloS one | 2013 |
Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells.
Esparza-López J, Medina-Franco H, Escobar-Arriaga E, León-Rodríguez E, Zentella-Dehesa A, Ibarra-Sánchez MJ |
Journal of Cancer Research and Clinical Oncology | 2013 |
Inflammation, Oxidative Stress, and Cancer: Dietary Approaches for Cancer Prevention
K Simmons, WL Wang, M Tenniswood, JE Welsh |
Inflammation, Oxidative Stress, and Cancer: Dietary Approaches for Cancer Prevention | 2013 |
Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells
J Esparza-López, H Medina-Franco, E Escobar-Arriaga, E León-Rodríguez, A Zentella-Dehesa, MJ Ibarra-Sánchez |
Journal of Cancer Research and Clinical Oncology | 2013 |
I B- controls the constitutive NF- B target gene network and survival of ABC DLBCL
H Nogai, SS Wenzel, S Hailfinger, M Grau, E Kaergel, V Seitz, B Wollert-Wulf, M Pfeifer, A Wolf, M Frick, K Dietze, H Madle, A Tzankov, M Hummel, B Dorken, C Scheidereit, M Janz, P Lenz, M Thome, G Lenz |
Blood | 2013 |
Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma
B Yan, H Li, X Yang, J Shao, M Jang, D Guan, S Zou, CV Waes, Z Chen, M Zhan |
PloS one | 2013 |
Nickel ion inhibits nuclear factor-kappa B activity in human oral squamous cell carcinoma
T Shionome, S Endo, D Omagari, M Asano, H Toyoma, T Ishigami, K Komiyama |
PloS one | 2013 |
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κB
G Fiume, A Rossi, A Laurentiis, C Falcone, A Pisano, E Vecchio, M Pontoriero, I Scala, A Scialdone, FF Masci, S Mimmi, C Palmieri, G Scala, I Quinto |
PloS one | 2013 |
Biomarkers in advanced larynx cancer
CR Bradford, B Kumar, E Bellile, J Lee, J Taylor, N D'Silva, K Cordell, C Kleer, R Kupfer, P Kumar, S Urba, F Worden, A Eisbruch, GT Wolf, TN Teknos, ME Prince, DB Chepeha, ND Hogikyan, JS Moyer, TE Carey |
The Laryngoscope | 2013 |
Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer
LK Nottingham, CH Yan, X Yang, H Si, J Coupar, Y Bian, TF Cheng, C Allen, P Arun, D Gius, L Dang, CV Waes, Z Chen |
Oncogene | 2013 |
Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma
AH Benz, C Renné, E Maronde, M Koch, U Grabiec, S Kallendrusch, B Rengstl, S Newrzela, S Hartmann, ML Hansmann, F Dehghani, P Mukhopadhyay |
PloS one | 2013 |
Hodgkin lymphoma: a unique lymphoid malignancy
Ralf Kueppers, Andreas Engert, Martin-Leo Hansmann |
Journal of Clinical Investigation | 2012 |
Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies : NF-κB in lymphoid cancer
KH Lim, Y Yang, LM Staudt |
Immunological Reviews | 2012 |
Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications
L la Cruz-Merino, M Lejeune, EN Fernández, FH Carrasco, AG López, AI Vacas, MP Pulla, C Callau, T Alvaro |
Clinical and Developmental Immunology | 2012 |
The in vitro study of apoptosis in NB4 cell induced by citral
H Xia, W Liang, Q Song, X Chen, X Chen, J Hong |
Cytotechnology | 2012 |
It takes two to tango: IκBs, the multifunctional partners of NF-κB : Biological roles of IκB family proteins
M Hinz, SÇ Arslan, C Scheidereit |
Immunological Reviews | 2012 |
Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma
C Otto, M Giefing, A Massow, I Vater, S Gesk, M Schlesner, J Richter, W Klapper, ML Hansmann, R Siebert, R Küppers |
British Journal of Haematology | 2012 |
Morphoproteomic confirmation of an activated nuclear factor-кBp65 pathway in follicular thyroid carcinoma
J Liu, RE Brown |
International journal of clinical and experimental pathology | 2012 |
Clinical Radiation Oncology
CA Barker, J Yahalom |
Clinical Radiation Oncology | 2012 |
Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells:
AM Castro-Gamero, KS Borges, VS Silveira, RC Lira, RP Queiroz, FC Valera, CA Scrideli, K Umezawa, LG Tone |
Anti-Cancer Drugs | 2012 |
Relationship between NF-^|^kappa;B Expression and Malignancy of Canine Mammary Gland Tumor Tissues
L MKAOUAR, Y ENDO, HX JUN, SJ LEE, T JAROENSONG, M MOCHIZUKI, K UCHIDA, H NAKAYAMA, N SASAKI, T NAKAGAWA |
Journal of Veterinary Medical Science | 2012 |
The nuclear factor-κB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma
Y Yin, X Si, Y Gao, L Gao, J Wang |
Oncology reports | 2012 |
Id2 regulates the proliferation of squamous cell carcinoma in vitro via the NF-κB/Cyclin D1 pathway
C Wang, Q Chen, Y Hamajima, W Sun, YQ Zheng, XH Hu, FG Ondrey, JZ Lin |
Chinese journal of cancer | 2012 |
To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator
D Sorriento, M Illario, R Finelli, G Iaccarino |
Translational medicine @ UniSa | 2012 |
Identification of a Novel Calotropis procera Protein That Can Suppress Tumor Growth in Breast Cancer through the Suppression of NF-κB Pathway
RP Samy, P Rajendran, F Li, NM Anandi, BG Stiles, S Ignacimuthu, G Sethi, VT Chow, MG Castro |
PloS one | 2012 |
Analysis of NF- κ B Pathway Proteins in Pediatric Hodgkin Lymphoma: Correlations with EBV Status and Clinical Outcome—A Children's Oncology Group Study
TM Horton, AM Sheehan, RE Hutchison, S Narendra, MF Wu, H Liu |
Lymphoma | 2012 |
Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics
J Tao, E Sotomayor |
2012 | |
Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma
HJ Jung, Z Chen, L Fayad, M Wang, J Romaguera, LW Kwak, N McCarty |
Experimental Hematology | 2011 |
Inflammation and Gastrointestinal Cancers
JA Jankowski |
2011 | |
Inflammation and Gastrointestinal Cancers
JA Jankowski |
2011 | |
Inflammation and Gastrointestinal Cancers
JA Jankowski |
2011 | |
Inflammation and Gastrointestinal Cancers
JA Jankowski |
2011 | |
Targetable molecular pathways in classical Hodgkin's lymphoma
H Adams, EC Obermann, S Dirnhofer, A Tzankov |
Expert Opinion on Investigational Drugs | 2011 |
Immune suppression in head and neck cancers: a review
A Duray, S Demoulin, P Hubert, P Delvenne, S Saussez |
Clinical & developmental immunology | 2011 |
The Role of Chalcones in Suppression of NF-κB-Mediated Inflammation and Cancer
VR Yadav, S Prasad, B Sung, BB Aggarwal |
International Immunopharmacology | 2011 |
Oxidative Stress and Disease
I Paur, M Carlsen, B Halvorsen, R Blomhoff |
Herbal Medicine | 2011 |
Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response
S Gardam, VM Turner, H Anderton, S Limaye, A Basten, F Koentgen, DL Vaux, J Silke, R Brink |
Blood | 2011 |
Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin’s Lymphoma - a population-based study
I Glimelius, J Rubin, K Rostgaard, RM Amini, M Simonsson, KM Sorensen, KE Smedby, P Venge, H Hjalgrim, D Molin, G Enblad |
European Journal of Haematology | 2011 |
The molecular pathogenesis of Hodgkin lymphoma
K Farrell, RF Jarrett |
Histopathology | 2011 |
Bfl-1 is a crucial pro-survival nuclear factor-κB target gene in Hodgkin/Reed-Sternberg cells
ST Loughran, EM Campion, BN D'Souza, SM Smith, K Vrzalikova, K Wen, PG Murray, D Walls |
International Journal of Cancer | 2011 |
Bioimaging analysis of nuclear factor-κB activity in Philadelphia chromosome-positive acute lymphoblastic leukemia cells reveals its synergistic upregulation by tumor necrosis factor-α-stimulated changes to the microenvironment
HJ Tsai, S Kobayashi, K Izawa, T Ishida, T Watanabe, K Umezawa, SF Lin, A Tojo |
Cancer Science | 2011 |
The aromatic ketone 4′-hydroxychalcone inhibits TNFα-induced NF-κB activation via proteasome inhibition
B Orlikova, D Tasdemir, F Golais, M Dicato, M Diederich |
Biochemical Pharmacology | 2011 |
Ets-1 Activates Overexpression of JunB and CD30 in Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma
M Watanabe, K Itoh, T Togano, ME Kadin, T Watanabe, M Higashihara, R Horie |
The American Journal of Pathology | 2011 |
Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed–Sternberg cells
R Schwarzer, B Dörken, F Jundt |
Leukemia | 2011 |
Immunohistology of Hodgkin Lymphoma
P Bhargava, ME Kadin |
Diagnostic Immunohistochemistry | 2011 |
Beta-catenin signalling: no relevance in Hodgkin lymphoma?
K Sohlbach, R Moll, J Goßmann, O Nowak, P Barth, A Neubauer, MQ Huynh |
Leukemia and Lymphoma | 2011 |
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken |
Advances in Cancer Research Volume 110 | 2011 |
Quantifying Nuclear p65 as a Parameter for NF-κB Activation: Correlation Between ImageStream Cytometry, Microscopy and Western Blot
O Maguire, C Collins, K O'Loughlin, J Miecznikowski, H Minderman |
Cytometry Part A | 2011 |
Mammalian target of rapamycin and head and neck squamous cell carcinoma
YM Liao, C Kim, Y Yen |
Head & neck oncology | 2011 |
Enforced expression of nuclear factor kappa B in p53 deficient keratinocytes induces cell cycle, angiogenic potential and tumorigenesis
EE Caicedo-Granados, BR Wuertz, FG Ondrey |
Oral Oncology | 2011 |
Effects of NF-κB Expression and Its Inhibition on Canine Mammary Cancer Cell Lines in an Immunodeficient Mice Model
L MKAOUAR, Y ENDO, M MOCHIZUKI, R NISHIMURA, N SASAKI, T NAKAGAWA |
Journal of Veterinary Medical Science | 2011 |
Diagnostic Immunohistochemistry
SP Hammar, S Dacic |
Diagnostic Immunohistochemistry | 2011 |
C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction
JE Dooher, I Paz-Priel, S Houng, AS Baldwin, AD Friedman |
Molecular cancer research : MCR | 2011 |
Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment
S Montes-Moreno |
Advances in Hematology | 2011 |
Hodgkin Disease and the Role of the Immune System
AA Kennedy-Nasser, P Hanley, CM Bollard |
Pediatric Hematology-Oncology | 2011 |
Cancer Associated Viruses
ES Robertson |
2011 | |
Epigenetic Contributions in Autoimmune Disease
E Ballestar |
2011 | |
Bioimaging analysis of nuclear factor‐κB activity in Philadelphia chromosome‐positive acute lymphoblastic leukemia cells reveals its synergistic upregulation by tumor necrosis factor‐α‐stimulated changes to the microenvironment
Tsai H, Kobayashi S, Izawa K, Ishida T, Watanabe T, Umezawa K, Lin S, Tojo A |
Cancer Science | 2011 |
3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps"
H Knecht, S Brüderlein, S Wegener, D Lichtensztejn, Z Lichtensztejn, B Lemieux, P Möller, S Mai |
BMC cell biology | 2010 |
Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease
ML Bangaru, J Woodliff, H Raff, S Kansra |
PloS one | 2010 |
Oncogenic activation of NF-kappaB
LM Staudt |
Cold Spring Harbor perspectives in biology | 2010 |
NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma
SS Han, H Yun, DJ Son, VS Tompkins, L Peng, ST Chung, JS Kim, ES Park, S Janz |
Molecular Cancer | 2010 |
Activating transcription factor-2 in survival mechanisms in head and neck carcinoma cells
D Duffey, S Dolgilevich, S Razzouk, L Li, R Green, GK Gorti |
Head & Neck | 2010 |
Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells
J Stanelle, C Doring, ML Hansmann, R Kuppers |
Blood | 2010 |
Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice
A Ahmad, JS Groshong, H Matta, S Schamus, V Punj, LJ Robinson, PS Gill, PM Chaudhary |
Cancer biology & therapy | 2010 |
Sp1/NFκB/HDAC/miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia
S Liu, LC Wu, J Pang, R Santhanam, S Schwind, YZ Wu, CJ Hickey, J Yu, H Becker, K Maharry, MD Radmacher, C Li, SP Whitman, A Mishra, N Stauffer, AM Eiring, R Briesewitz, RA Baiocchi, KK Chan, P Paschka, MA Caligiuri, JC Byrd, CM Croce, CD Bloomfield, D Perrotti, R Garzon, G Marcucci |
Cancer Cell | 2010 |
DJ-1 Enhances Cell Survival through the Binding of Cezanne, a Negative Regulator of NF-κB*
RS McNally, BK Davis, CM Clements, MA Accavitti-Loper, TW Mak, JP Ting |
The Journal of biological chemistry | 2010 |
Pediatric Hematology and Oncology
S Weitzman, RM Egeler |
Pediatric Hematology and Oncology | 2010 |
Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in northern Denmark
ET Chang, DP Cronin-Fenton, S Friis, H Hjalgrim, HT Sørensen, L Pedersen |
Cancer epidemiology, biomarkers & prevention | 2010 |
Tissue-microarray based immunohistochemical analysis of survival pathways in nodular sclerosing classical Hodgkin lymphoma as compared with Non-Hodgkin's lymphoma
J De, RE Brown |
International journal of clinical and experimental medicine | 2010 |
A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma
PB Johnston, DJ Inwards, JP Colgan, BR Laplant, BF Kabat, TM Habermann, IN Micallef, LF Porrata, SM Ansell, CB Reeder, V Roy, TE Witzig |
American Journal of Hematology | 2010 |
Herpesvirus-associated lymphomas: Investigations in humans and animal models
J Rajčáni, N Ásványi-Molnár, S Szathmary |
Acta Microbiologica et Immunologica Hungarica | 2010 |
Physiological effects of resveratrol
H Kalantari, DK Das |
BioFactors | 2010 |
Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells
D Sumi, Y Shinkai, Y Kumagai |
Toxicology and Applied Pharmacology | 2010 |
Apoptosis of Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma revisited
D Benharroch, I Einav, A Feldman, A Levy, S Ariad, J Gopas |
APMIS | 2010 |
Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κB
SM Kim, SY Lee, JS Cho, SM Son, SS Choi, YP Yun, HS Yoo, DY Yoon, KW Oh, SB Han, JT Hong |
European Journal of Pharmacology | 2010 |
Dominant expression of survival signals of endoplasmic reticulum stress response in Hodgkin lymphoma
KC Chang, PC Chen, YP Chen, Y Chang, IJ Su |
Cancer Science | 2010 |
Captivating Bortezomib: An active but still mysterious drug
FD Raimondo, C Conticello |
Leukemia Research | 2010 |
Deficiency of tenascin-C delays articular cartilage repair in mice
N Okamura, M Hasegawa, Y Nakoshi, T Iino, A Sudo, K Imanaka-Yoshida, T Yoshida, A Uchida |
Osteoarthritis and Cartilage | 2010 |
Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols
W Suttana, S Mankhetkorn, W Poompimon, A Palagani, S Zhokhov, S Gerlo, G Haegeman, WV Berghe |
Molecular Cancer | 2010 |
Inhibiting NF-κB Activation by Small Molecules As a Therapeutic Strategy
SC Gupta, C Sundaram, S Reuter, BB Aggarwal |
Biochimica et Biophysica Acta | 2010 |
Correlation of NF-κB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma
M Yan, Q Xu, P Zhang, X Zhou, Z Zhang, W Chen |
BMC Cancer | 2010 |
Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
A Jona, A Younes |
Blood Reviews | 2010 |
PYRIN domain of NALP2 inhibits cell proliferation and tumor growth of human glioblastoma
GQ Wu, YJ Liao, ZQ Qin, LR He, YC Chen, YX Zeng, HF Kung, D Xie |
Plasmid | 2010 |
Brucea javanica Oil Induces Apoptosis in T24 Bladder Cancer Cells via Upregulation of Caspase-3, Caspase-9, and Inhibition of NF-κB and COX-2 Expressions
GG Lou, HP Yao, LP Xie |
The American journal of Chinese medicine | 2010 |
Mutations of NFKBIA in biopsy specimens from Hodgkin lymphoma
X Liu, H Yu, W Yang, X Zhou, H Lu, D Shi |
Cancer Genetics and Cytogenetics | 2010 |
3D structural and functional characterization of the transition from Hodgkin to Reed-Sternberg cells
H Knecht, S Brüderlein, S Mai, P Möller, B Sawan |
Annals of Anatomy - Anatomischer Anzeiger | 2010 |
NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia
M Breccia, G Alimena |
Expert Opinion on Therapeutic Targets | 2010 |
DJ-1 Enhances Cell Survival through the Binding of Cezanne, a Negative Regulator of NF-κB
RS McNally, BK Davis, CM Clements, MA Accavitti-Loper, TW Mak, JP Ting |
The Journal of biological chemistry | 2010 |
Molecular Pathology of Hematolymphoid Diseases
CH Dunphy |
2010 | |
Nasopharyngeal Cancer
JJ Lu, JS Cooper, AW Lee |
2010 | |
A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFκB activity
D Sorriento, A Campanile, G Santulli, E Leggiero, L Pastore, B Trimarco, G Iaccarino |
Molecular Cancer | 2009 |
Regulation and Function of NF-κB Transcription Factors in the Immune System
S Vallabhapurapu, M Karin |
Annual Review of Immunology | 2009 |
Epstein-Barr Virus in Lymphoproliferative Processes
SB Ng, JD Khoury |
Advances in Anatomic Pathology | 2009 |
The integrin alpha2beta1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-kB translocation and PDGF production
CH Chung, KT Lin, CH Chang, HC Peng, TF Huang |
British Journal of Pharmacology | 2009 |
Characterization of anti-NF-kappaB RNA aptamer-binding specificity in vitro and in the yeast three-hybrid system
SE Wurster, JP Bida, YF Her, LJ 3rd |
Nucleic Acids Research | 2009 |
EBV in Hodgkin Lymphoma
G Massini, D Siemer, S Hohaus |
Mediterranean journal of hematology and infectious diseases | 2009 |
NF-kappaB and cancer: how intimate is this relationship
S Prasad, J Ravindran, BB Aggarwal |
Molecular and Cellular Biochemistry | 2009 |
Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma
LF Sniderhan, TM Garcia-Bates, M Burgart, SH Bernstein, RP Phipps, SB Maggirwar |
Experimental Hematology | 2009 |
Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma
MA Schumacher, R Schmitz, V Brune, E Tiacci, C Döring, ML Hansmann, R Siebert, R Küppers |
Haematologica | 2009 |
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
R Schmitz, ML Hansmann, V Bohle, JI Martin-Subero, S Hartmann, G Mechtersheimer, W Klapper, I Vater, M Giefing, S Gesk, J Stanelle, R Siebert, R Küppers |
Journal of Experimental Medicine | 2009 |
Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes
N Faumont, A Chanut, A Benard, N Cogne, G Delsol, J Feuillard, F Meggetto |
Haematologica | 2009 |
Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma
L Alinari, VL White, CT Earl, TP Ryan, JS Johnston, JT Dalton, AK Ferketich, R Lai, DM Lucas, P Porcu, KA Blum, JC Byrd, RA Baiocchi |
mAbs | 2009 |
Loss of endogenous interleukin-12 activates survival signals in ultraviolet-exposed mouse skin and skin tumors
SM Meeran, N Katiyar, T Singh, SK Katiyar |
Neoplasia (New York, N.Y.) | 2009 |
Proteasome Inhibitor MG132 Inhibits Angiogenesis in Pancreatic Cancer by Blocking NF-κB Activity
Y Matsuo, H Sawai, N Ochi, A Yasuda, M Sakamoto, H Takahashi, H Funahashi, H Takeyama, S Guha |
Digestive Diseases and Sciences | 2009 |
STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line
D Baus, F Nonnenmacher, S Jankowski, C Döring, C Bräutigam, M Frank, ML Hansmann, E Pfitzner |
Leukemia | 2009 |
Mutations ofNFKBIA, encoding IκBα, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases
A Lake, LA Shield, P Cordano, DT Chui, J Osborne, S Crae, KS Wilson, S Tosi, SJ Knight, S Gesk, R Siebert, RT Hay, RF Jarrett |
International Journal of Cancer | 2009 |
Heat stress triggers apoptosis by impairing NF-κB survival signaling in malignant B cells
G Belardo, R Piva, MG Santoro |
Leukemia | 2009 |
Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
A Younes |
Hematology | 2009 |
Molecular biology of Hodgkin lymphoma
R Kuppers |
Hematology | 2009 |
TRAF1 is involved in the classical NF-κB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells
F Guo, A Sun, W Wang, J He, J Hou, P Zhou, Z Chen |
Molecular Immunology | 2009 |
Pathogenesis of Classical and Lymphocyte-Predominant Hodgkin Lymphoma
R Schmitz, J Stanelle, ML Hansmann, R Küppers |
Annual Review of Pathology: Mechanisms of Disease | 2009 |
Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate–gene association study
V Mollaki, T Georgiadis, A Tassidou, M Ioannou, Z Daniil, A Koutsokera, AA Papathanassiou, E Zintzaras, G Vassilopoulos |
Journal of Human Genetics | 2009 |
Functional aspects of the CD30 gene in Hodgkin’s lymphoma and anaplastic large cell lymphoma
DS Ho, AJ Rea, LJ Abraham |
Oncology Reviews | 2009 |
Epigenetic dysregulation of the host cell genome in Epstein–Barr virus-associated neoplasia
HH Niller, H Wolf, J Minarovits |
Seminars in Cancer Biology | 2009 |
Targeting the Bcl-2 family of proteins in Hodgkin lymphoma:in vitrocytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737
A Jayanthan, SC Howard, T Trippett, T Horton, JA Whitlock, L Daisley, V Lewis, A Narendran |
Leukemia & Lymphoma | 2009 |
Fighting Cancer with Red Wine? Molecular Mechanisms of Resveratrol
TE Kraft, D Parisotto, C Schempp, T Efferth |
Critical Reviews in Food Science and Nutrition | 2009 |
Oncology of Infancy and Childhood
MJ O'Sullivan, JA Fletcher, CA Felix |
Oncology of Infancy and Childhood | 2009 |
Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and augmented by ubiquitin-proteasome inhibition
C Wang, S Li, M Wang |
Toxicology in vitro : an international journal published in association with BIBRA | 2009 |
K-Ras Promotes Angiogenesis Mediated by Immortalized Human Pancreatic Epithelial Cells through Mitogen-Activated Protein Kinase Signaling Pathways
Y Matsuo, PM Campbell, RA Brekken, B Sung, MM Ouellette, JB Fleming, BB Aggarwal, CJ Der, S Guha |
Molecular cancer research : MCR | 2009 |
Lymphoma in Adolescents and Young Adults
SM Jaglowski, E Linden, AM Termuhlen, JM Flynn |
Seminars in Oncology | 2009 |
Exhaled Nitric Oxide and Nitric Oxide Synthase Expression in Hodgkin's Disease
G Guida, B Culla, T Scirelli, G Bellone, S Sciascia, L Brussino, D Novero, G Palestro, E Heffler, P Gavarotti, G Rolla, C Bucca |
International journal of immunopathology and pharmacology | 2009 |
Obovatol Enhances Docetaxel-Induced Prostate and Colon Cancer Cell Death Through Inactivation of Nuclear Transcription Factor-κB
SY Lee, JS Cho, DY Yuk, DC Moon, JK Jung, HS Yoo, YM Lee, SB Han, KW Oh, JT Hong |
Journal of Pharmacological Sciences | 2009 |
Drug Resistance in Cancer Cells
ZH Siddik, K Mehta |
2009 | |
Polymorphic Variation in NFKB1 and Other Aspirin-Related Genes and Risk of Hodgkin Lymphoma
ET Chang, BM Birmann, JL Kasperzyk, DV Conti, P Kraft, RF Ambinder, T Zheng, NE Mueller |
Cancer epidemiology, biomarkers & prevention | 2009 |
Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells
Y Saitoh, N Yamamoto, MZ Dewan, H Sugimoto, VJ Bruyn, Y Iwasaki, K Matsubara, X Qi, T Saitoh, I Imoto, J Inazawa, A Utsunomiya, T Watanabe, T Masuda, N Yamamoto, S Yamaoka |
Blood | 2008 |
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis
V Brune, E Tiacci, I Pfeil, C Döring, S Eckerle, CJ van Noesel, W Klapper, B Falini, A Heydebreck, D Metzler, A Bräuninger, ML Hansmann, R Küppers |
Journal of Experimental Medicine | 2008 |
CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells
B Hirsch, M Hummel, S Bentink, F Fouladi, R Spang, R Zollinger, H Stein, H Dürkop |
The American Journal of Pathology | 2008 |
Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis
J Chou, YC Lin, J Kim, L You, Z Xu, B He, DM Jablons |
Head & Neck | 2008 |
Programmed Cell Death in Cancer Progression and Therapy
R Khosravi-Far, E White |
2008 | |
Programmed Cell Death in Cancer Progression and Therapy
R Khosravi-Far, E White |
2008 | |
Programmed Cell Death in Cancer Progression and Therapy
R Khosravi-Far, E White |
2008 | |
Programmed Cell Death in Cancer Progression and Therapy
R Khosravi-Far, E White |
2008 | |
Programmed Cell Death in Cancer Progression and Therapy
R Khosravi-Far, E White |
2008 | |
Programmed Cell Death in Cancer Progression and Therapy
R Khosravi-Far, E White |
2008 | |
Regulation and dysregulation of Epstein–Barr virus latency: Implications for the development of autoimmune diseases
HH Niller, H Wolf, J Minarovits |
Autoimmunity | 2008 |
IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis
FA Scheeren, SA Diehl, LA Smit, T Beaumont, M Naspetti, RJ Bende, B Blom, K Karube, K Ohshima, CJ van Noesel, H Spits |
Blood | 2008 |
Prednisolone inhibits PDGF-induced nuclear translocation of NF-kappaB in human pulmonary artery smooth muscle cells
A Ogawa, AL Firth, W Yao, LJ Rubin, JX Yuan |
American journal of physiology. Lung cellular and molecular physiology | 2008 |
Retracted: A modified version of galectin-9 induces cell cycle arrest and apoptosis of Burkitt and Hodgkin lymphoma cells
S Makishi, T Okudaira, C Ishikawa, S Sawada, T Watanabe, M Hirashima, H Sunakawa, N Mori |
British Journal of Haematology | 2008 |
Nuclear factor-κB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas
FF Angileri, MH Aguennouz, A Conti, DL Torre, S Cardali, R Crupi, C Tomasello, A Germanò, G Vita, F Tomasello |
Cancer | 2008 |
Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins
N Gupta, J Delrow, A Drawid, AM Sengupta, G Fan, C Gélinas |
Cancer research | 2008 |
Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
DT Yang, KH Young, BS Kahl, S Markovina, S Miyamoto |
Molecular Cancer | 2008 |
The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death
SJ Lee, M Long, AJ Adler, RS Mittler, AT Vella |
Journal of leukocyte biology | 2008 |
A distinctive physiological role for IkappaBbeta in the propagation of mitochondrial respiratory stress signaling
G Biswas, W Tang, N Sondheimer, M Guha, S Bansal, NG Avadhani |
The Journal of biological chemistry | 2008 |
Apoptosis and tumor resistance conferred by Par-4
Y Zhao, VM Rangnekar |
Cancer biology & therapy | 2008 |
IKK-2 is required for TNF-α-induced invasion and proliferation of human mesenchymal stem cells
W Böcker, D Docheva, WC Prall, V Egea, E Pappou, O Roßmann, C Popov, W Mutschler, C Ries, M Schieker |
Journal of Molecular Medicine | 2008 |
Plumbagin-induced Apoptosis in Human Prostate Cancer Cells is Associated with Modulation of Cellular Redox Status and Generation of Reactive Oxygen Species
AA Powolny, SV Singh |
Pharmaceutical Research | 2008 |
Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-κB and STAT3 pathways in Hodgkin's lymphoma cells
GG Mackenzie, N Queisser, ML Wolfson, CG Fraga, AM Adamo, PI Oteiza |
International Journal of Cancer | 2008 |
Role of immunoexpression of nitric oxide synthases by Hodgkin and Reed-Sternberg cells on apoptosis deregulation and on clinical outcome of classical Hodgkin lymphoma
AH Campos, VL Aldred, KC Ribeiro, J Vassallo, FA Soares |
Molecular and Cellular Biochemistry | 2008 |
The role of NF-κB in lymphoid malignancies
G Packham |
British Journal of Haematology | 2008 |
Targetable oncogenic pathways in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma
A Tzankov |
memo - Magazine of European Medical Oncology | 2008 |
Inhibitory activity of nuclear factor-κB potentiates cisplatin-induced apoptosis in A549 cells
J Zhang, Y Xu, W Xiong, Z Zhang, C Du, L Qiao, W Ni, S Chen |
Journal of Huazhong University of Science and Technology [Medical Sciences] | 2008 |
Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: A gene expression profiling study with implications for potential combination therapies
X Zhao, W Qiu, J Kung, X Zhao, X Peng, M Yegappan, B Yen-Lieberman, ED Hsi |
Leukemia Research | 2008 |
NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases
FH Sarkar, Y Li, Z Wang, D Kong |
International Reviews of Immunology | 2008 |
Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: Tumor and microenvironment
ED Hsi |
Leukemia & Lymphoma | 2008 |
Stimulation of interleukin-13 expression by human T-cell leukemia virus type 1 oncoprotein Tax via a dually active promoter element responsive to NF- B and NFAT
K Silbermann, G Schneider, R Grassmann |
Journal of General Virology | 2008 |
Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein–Barr virus-associated B-cell lymphoproliferative disorder
S Takegawa, Z Jin, T Nakayama, T Oyama, K Hieshima, D Nagakubo, AK Shirakawa, T Tsuzuki, S Nakamura, O Yoshie |
Cancer Science | 2008 |
Expression of the translation initiation factors eIF-4E and eIF-2α is frequently increased in neoplastic cells of Hodgkin lymphoma
IB Rosenwald, L Koifman, L Savas, JJ Chen, BA Woda, ME Kadin |
Human Pathology | 2008 |
Systems biology-defined NF-κB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status
B Yan, G Chen, K Saigal, X Yang, ST Jensen, CV Waes, CJ Stoeckert, Z Chen |
Genome biology | 2008 |
The Role of the NF-kappaB Transcriptome and Proteome as Biomarkers in Human Head and Neck Squamous Cell Carcinomas*
Z Chen, B Yan, CV Waes |
Biomarkers in Medicine | 2008 |
Molecular Biology of Head & Neck Cancer: Risks and Pathways
ME Stadler, MR Patel, ME Couch, DN Hayes |
Hematology/Oncology Clinics of North America | 2008 |
Dynamic Effect of Bortezomib on NF-κB Activity and Gene Expression in Tumor Cells
MH Sung, L Bagain, Z Chen, T Karpova, X Yang, C Silvin, TC Voss, JG McNally, CV Waes, GL Hager |
Molecular pharmacology | 2008 |
Hematopathology
F Naeim |
Hematopathology | 2008 |
Anti-NF-kappaB and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling
A Prawan, CL Saw, TO Khor, YS Keum, S Yu, L Hu, AN Kong |
Chemico-Biological Interactions | 2008 |
A Distinctive Physiological Role for IκBβ in the Propagation of Mitochondrial Respiratory Stress Signaling
G Biswas, W Tang, N Sondheimer, M Guha, S Bansal, NG Avadhani |
The Journal of biological chemistry | 2008 |
Prednisolone inhibits PDGF-induced nuclear translocation of NF-κB in human pulmonary artery smooth muscle cells
A Ogawa, AL Firth, W Yao, LJ Rubin, JX Yuan |
American journal of physiology. Lung cellular and molecular physiology | 2008 |
Nuclear Factor-κB Activation: From Bench to Bedside
G Sethi, B Sung, BB Aggarwal |
Experimental biology and medicine (Maywood, N.J.) | 2008 |
Innate and Adaptive Immunity in the Tumor Microenvironment
E Yefenof |
2008 | |
CAPERα Is a Novel Rel-TAD-Interacting Factor That Inhibits Lymphocyte Transformation by the Potent Rel/NF-κB Oncoprotein v-Rel
J Dutta, G Fan, C Gélinas |
Journal of virology | 2008 |
Inhibitory activity of nuclear factor-kappaB potentiates cisplatin-induced apoptosis in A549 cells.
Zhang J, Xu Y, Xiong W, Zhang Z, Du C, Qiao L, Ni W, Chen S |
2008 | |
Role of immunoexpression of nitric oxide synthases by Hodgkin and Reed-Sternberg cells on apoptosis deregulation and on clinical outcome of classical Hodgkin lymphoma.
Campos AH, Aldred VL, Ribeiro KC, Vassallo J, Soares FA |
Molecular and Cellular Biochemistry | 2008 |
Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species.
Powolny AA, Singh SV |
Pharmaceutical Research | 2008 |
Expression of CCL17 and CCL22 by latent membrane protein 1‐positive tumor cells in age‐related Epstein–Barr virus‐associated B‐cell lymphoproliferative disorder
Takegawa S, Jin Z, Nakayama T, Oyama T, Hieshima K, Nagakubo D, Shirakawa A, Tsuzuki T, Nakamura S, Yoshie O |
Cancer Science | 2008 |
Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration
L Emdad, D Sarkar, ZZ Su, SG Lee, DC Kang, JN Bruce, DJ Volsky, PB Fisher |
Pharmacology & Therapeutics | 2007 |
The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease
BB Aggarwal, YJ Surh, S Shishodia |
2007 | |
The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease
BB Aggarwal, YJ Surh, S Shishodia |
2007 | |
The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease
BB Aggarwal, YJ Surh, S Shishodia |
2007 | |
Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome
DB Kerbauy, HJ Deeg |
Experimental Hematology | 2007 |
Targeted Therapies in Cancer
M Dietel |
2007 | |
EBV Latent Membrane Protein 1 Activates Akt, NFκB, and Stat3 in B Cell Lymphomas
KH Shair, KM Bendt, RH Edwards, EC Bedford, JN Nielsen, N Raab-Traub, S Virgin |
PLoS pathogens | 2007 |
Nuclear factor-κB-dependent cyclin D1 induction and DNA replication associated with N-methyl-D-aspartate receptor-mediated apoptosis in rat striatum
ZQ Liang, X Wang, LY Li, Y Wang, RW Chen, DM Chuang, TN Chase, ZH Qin |
Journal of Neuroscience Research | 2007 |
Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma
G Kapatai, P Murray |
Journal of clinical pathology | 2007 |
Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis
A Lietz, M Janz, M Sigvardsson, F Jundt, B Dörken, S Mathas |
British Journal of Haematology | 2007 |
Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells
M Janz, T Stühmer, LT Vassilev, RC Bargou |
Leukemia | 2007 |
Nitric oxide induces apoptosis in cutaneous T cell lymphoma (HuT-78) by downregulating constitutive NF-κB
L Rishi, R Dhiman, M Raje, S Majumdar |
Biochimica et Biophysica Acta (BBA) - General Subjects | 2007 |
High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma
C Renné, K Willenbrock, JI Martin-Subero, N Hinsch, C Döring, E Tiacci, W Klapper, P Möller, R Küppers, ML Hansmann, R Siebert, A Bräuninger |
Leukemia | 2007 |
Tissue transglutaminase-mediated chemoresistance in cancer cells
A Verma, K Mehta |
Drug Resistance Updates | 2007 |
Gains ofREL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein
MA Weniger, S Gesk, S Ehrlich, JI Martin-Subero, MJ Dyer, R Siebert, P Möller, TF Barth |
Genes, Chromosomes and Cancer | 2007 |
Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions
E Klein, LL Kis, G Klein |
Oncogene | 2007 |
NF-?B and apoptosis in colorectal tumourigenesis
MM Aranha, PM Borralho, P Ravasco, IB da Silva, L Correia, A Fernandes, ME Camilo, CM Rodrigues |
European Journal of Clinical Investigation | 2007 |
IκBα independent induction of NF-κB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells
M Watanabe, MZ Dewan, M Taira, M Shoda, M Honda, T Sata, M Higashihara, ME Kadin, T Watanabe, N Yamamoto, K Umezawa, R Horie |
Laboratory Investigation | 2007 |
Absence of measles virus genome and transcripts in Hodgkin-Reed/Sternberg cells of a cohort of Hodgkin lymphoma patients
E Maggio, D Benharroch, J Gopas, U Dittmer, ML Hansmann, R Küppers |
International Journal of Cancer | 2007 |
Arsenic: Signal Transduction, Transcription Factor, and Biotransformation Involved in Cellular Response and Toxicity
Y Kumagai, D Sumi |
Annual Review of Pharmacology and Toxicology | 2007 |
Transcription Factors as Therapeutic Targets in Lymphoid Malignancies
T Sanda |
International Reviews of Immunology | 2007 |
Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel
L Markasz, LL Kis, G Stuber, E Flaberg, R Otvos, S Eksborg, H Skribek, E Olah, L Szekely |
Leukemia & Lymphoma | 2007 |
Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed–Sternberg cell
MR Roullet, A Bagg |
Expert Review of Molecular Diagnostics | 2007 |
NF-κB controls growth of glioblastomas/astrocytomas
D Smith, T Shimamura, S Barbera, BE Bejcek |
Molecular and Cellular Biochemistry | 2007 |
TheCD30 gene promoter microsatellite binds transcription factor Yin Yang 1 (YY1) and shows genetic instability in anaplastic large cell lymphoma
M Franchina, AJ Woo, J Dods, M Karimi, D Ho, T Watanabe, DV Spagnolo, LJ Abraham |
The Journal of Pathology | 2007 |
Relapsed and Refractory Hodgkin Lymphoma: Transplantation Strategies and Novel Therapeutic Options
KA David, L Mauro, AM Evens |
Current Treatment Options in Oncology | 2007 |
Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas
M Bai, A Papoudou-Bai, N Horianopoulos, C Grepi, NJ Agnantis, P Kanavaros |
Human Pathology | 2007 |
The Pathogenesis of Classical Hodgkin's Lymphoma: A Model for B-Cell Plasticity
S Mathas |
Hematology/Oncology Clinics of North America | 2007 |
Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-κB and other signal transcription factors in head and neck squamous cell carcinoma
B Yan, X Yang, TL Lee, J Friedman, J Tang, CV Waes, Z Chen |
Genome biology | 2007 |
Perspectives in Medical Virology
KD Mena |
Perspectives in Medical Virology | 2007 |
Targeting Antiapoptotic Bcl-2 Family Members with Cell-Permeable BH3 Peptides Induces Apoptosis Signaling and Death in Head and Neck Squamous Cell Carcinoma Cells12
R Li, AL Boehm, MB Miranda, S Shangary, JR Grandis, DE Johnson |
Neoplasia (New York, N.Y.) | 2007 |
Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells
Y Ustundag, SF Bronk, GJ Gores |
World journal of gastroenterology : WJG | 2007 |
Nuclear factor-kB in thyroid carcinogenesis and progression: a novel therapeutic target for advanced thyroid cancer
H Namba, V Saenko, S Yamashita |
Arquivos brasileiros de endocrinologia e metabologia | 2007 |
Aids-Associated Viral Oncogenesis
C Meyers |
2007 | |
Pediatric Lymphomas
HJ Weinstein, MM Hudson, MP Link |
2007 | |
Cytokines in the Genesis and Treatment of Cancer
MA Caligiuri, MT Lotze |
2007 | |
NF-kappaB controls growth of glioblastomas/astrocytomas.
Smith D, Shimamura T, Barbera S, Bejcek BE |
Molecular and Cellular Biochemistry | 2007 |
Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.
David KA, Mauro L, Evens AM |
Current Treatment Options in Oncology | 2007 |
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL
A Chiu, W Xu, B He, SR Dillon, JA Gross, E Sievers, X Qiao, P Santini, E Hyjek, J Lee, E Cesarman, A Chadburn, DM Knowles, A Cerutti |
Blood | 2006 |
Epstein–Barr virus-associated lymphomas
MK Gandhi |
Expert Review of Anti-infective Therapy | 2006 |
Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case-control study (EPILYMPH)
H Besson, P Brennan, N Becker, SD Sanjosé, A Nieters, R Font, M Maynadié, L Foretova, PL Cocco, A Staines, M Vornanen, P Boffetta |
British Journal of Cancer | 2006 |
Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma
CH Squarize, RM Castilho, V Sriuranpong, DS Pinto, JS Gutkind |
Neoplasia (New York, N.Y.) | 2006 |
NF-κB: A Stress-Regulated Switch for Cell Survival
R Piva, G Belardo, MG Santoro |
Antioxidants & Redox Signaling | 2006 |
The role of Epstein–Barr virus in cancer
SB Pattle, PJ Farrell |
Expert Opinion on Biological Therapy | 2006 |
Cytokine mediated induction of the major Epstein–Barr virus (EBV)-encoded transforming protein, LMP-1
LL Kis, M Takahara, N Nagy, G Klein, E Klein |
Immunology Letters | 2006 |
Hodgkin’s lymphoma: molecular targets and novel treatment strategies
V Yazbeck, GV Georgakis, A Wedgwood, A Younes |
Future Oncology | 2006 |
Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: Report of 21 cases and review of the literature
V Audard, F Larousserie, P Grimbert, M Abtahi, JJ Sotto, A Delmer, F Boue, D Nochy, N Brousse, R Delarue, P Remy, P Ronco, D Sahali, P Lang, O Hermine |
Kidney International | 2006 |
The effect of Epstein–Barr virus status on clinical outcome in Hodgkin’s lymphoma
JM Kwon, YH Park, JH Kang, K Kim, YH Ko, BY Ryoo, SS Lee, SI Lee, HH Koo, WS Kim |
Annals of Hematology | 2006 |
Targeting NF-κB in hematologic malignancies
T Braun, G Carvalho, C Fabre, J Grosjean, P Fenaux, G Kroemer |
Cell Death and Differentiation | 2006 |
NF-κB and IKK as therapeutic targets in cancer
HJ Kim, N Hawke, AS Baldwin |
Cell Death and Differentiation | 2006 |
Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma
A Bräuninger, R Schmitz, D Bechtel, C Renné, ML Hansmann, R Küppers |
International Journal of Cancer | 2006 |
The involvement of nuclear factor-kappa B in cyclooxygenase-2 overexpression in murine colon cancer cells transduced with herpes simplex virus thymidine kinase gene
A Konson, JA Mahajna, A Danon, G Rimon, R Agbaria |
Cancer Gene Therapy | 2006 |
Current insights into the regulation of programmed cell death by NF-κB
J Dutta, Y Fan, N Gupta, G Fan, C Gélinas |
Oncogene | 2006 |
Mutations in the NF-κB signaling pathway: implications for human disease
G Courtois, TD Gilmore |
Oncogene | 2006 |
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
DS Bassères, AS Baldwin |
Oncogene | 2006 |
Thalidomide and celecoxib as potential modulators of irinotecan’s activity in cancer patients
M Villalona-Calero, L Schaaf, G Phillips, G Otterson, K Panico, W Duan, B Kleiber, M Shah, D Young, WH Wu, J Kuhn |
Cancer Chemotherapy and Pharmacology | 2006 |
Gene expression profiling of breast cancer cells in response to gemcitabine: NF-κB pathway activation as a potential mechanism of resistance
H Hernández-Vargas, SM Rodríguez-Pinilla, M Julián-Tendero, P Sánchez-Rovira, C Cuevas, A Antón, MJ Ríos, J Palacios, G Moreno-Bueno |
Breast Cancer Research and Treatment | 2006 |
Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells
D Baus, E Pfitzner |
International Journal of Cancer | 2006 |
Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin's lymphoma
A Feuerborn, C Möritz, FV Bonin, M Dobbelstein, L Trümper, B Stürzenhofecker, D Kube |
Leukemia & Lymphoma | 2006 |
Epstein-Barr virus, cytokines, and inflammation: A cocktail for the pathogenesis of Hodgkin's lymphoma?
G Khan |
Experimental Hematology | 2006 |
Signalling and survival pathways in multiple myeloma
K Bommert, RC Bargou, T Stühmer |
European Journal of Cancer | 2006 |
Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane
S Karmakar, MS Weinberg, NL Banik, SJ Patel, SK Ray |
Neuroscience | 2006 |
Handbook of Transcription Factor NF-kappaB
A Baldwin |
Handbook of Transcription Factor NF-kappaB | 2006 |
NF-κB in solid tumors
F Pacifico, A Leonardi |
Biochemical Pharmacology | 2006 |
Proteasome inhibitors and modulators of heat shock protein function
DJ Kuhn, EL Zeger, RZ Orlowski |
Update on cancer therapeutics | 2006 |
Molecular Cross-Talk between the NFκB and STAT3 Signaling Pathways in Head and Neck Squamous Cell Carcinoma
CH Squarize, RM Castilho, V Sriuranpong, DS Pinto, JS Gutkind |
Neoplasia (New York, N.Y.) | 2006 |
Deregulated NF-κB activity in haematological malignancies
A Keutgens, I Robert, P Viatour, A Chariot |
Biochemical Pharmacology | 2006 |
Advances in Biology, Diagnostics, and Treatment of Hodgkin’s Disease
R Küppers, J Yahalom, A Josting |
Biology of Blood and Marrow Transplantation | 2006 |
Modulation of transcription factor NF-κB in Hodgkin's lymphoma cell lines: Effect of (−)-epicatechin
GG Mackenzie, PI Oteiza |
Free Radical Research | 2006 |
The Link Between Inflammation and Cancer
AG Dalgleish, B Haefner |
2006 | |
Pathobiology of Classical Hodgkin Lymphoma
A Tzankov, S Dirnhofer |
Pathobiology | 2006 |
NF-κB/Rel Transcription Factor Family
HC Liou |
2006 | |
Classical Hodgkin lymphoma: an epigenetically determined disease?
JF García |
Blood | 2006 |
Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications
PJ Jost, J Ruland |
Blood | 2006 |
Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells
A Dutton, CB Woodman, MB Chukwuma, JI Last, W Wei, M Vockerodt, KR Baumforth, JR Flavell, M Rowe, AM Taylor, LS Young, PG Murray |
Blood | 2006 |
A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas
F Jundt, N Raetzel, C Müller, CF Calkhoven, K Kley, S Mathas, A Lietz, A Leutz, B Dörken |
Blood | 2005 |
Immunobiology and Pathophysiology of Hodgkin Lymphomas
S Poppema |
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 2005 |
Role of nuclear factor-kappa B in melanoma
KI Amiri, A Richmond |
Cancer metastasis reviews | 2005 |
NF-κB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs)
DM Kerbauy, V Lesnikov, N Abbasi, S Seal, B Scott, HJ Deeg |
Blood | 2005 |
Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma
C Renné, K Willenbrock, R Küppers, ML Hansmann, A Bräuninger |
Blood | 2005 |
Viruses and lymphoma
MK Gandhi, R Khanna |
Pathology | 2005 |
Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas
R Schmitz, C Renné, R Rosenquist, M Tinguely, V Distler, F Menestrina, M Lestani, T Stankovic, B Austen, A Bräuninger, ML Hansmann, R Küppers |
Leukemia | 2005 |
Comparative animal models for the study of lymphohematopoietic tumors: strengths and limitations of present approaches
OA O'Connor, LE Toner, R Vrhovac, T Budak-ALpdogan, EA Smith, P Bergman |
Leukemia & Lymphoma | 2005 |
The biology of human lymphoid malignancies revealed by gene expression profiling
LM Staudt, S Dave |
Advances in immunology | 2005 |
Feverfew: weeding out the root of leukaemia
ML Guzman, CT Jordan |
Expert Opinion on Biological Therapy | 2005 |
LMP1 signaling and activation of NF-κB in LMP1 transgenic mice
NJ Thornburg, W Kulwichit, RH Edwards, KH Shair, KM Bendt, N Raab-Traub |
Oncogene | 2005 |
Problems and promises of targeted therapy for Hodgkin's lymphoma
D Re, RK Thomas, T Zander, V Diehl |
Nature Clinical Practice Oncology | 2005 |
Aberrant NF-κB2/p52 expression in Hodgkin/Reed–Sternberg cells and CD30-transformed rat fibroblasts
M Nonaka, R Horie, K Itoh, T Watanabe, N Yamamoto, S Yamaoka |
Oncogene | 2005 |
STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis
U Holtick, M Vockerodt, D Pinkert, N Schoof, B Stürzenhofecker, N Kussebi, K Lauber, S Wesselborg, D Löffler, F Horn, L Trümper, D Kube |
Leukemia | 2005 |
Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD/SCID/gammacnull mice
MZ Dewan, M Watanabe, S Ahmed, K Terashima, S Horiuchi, T Sata, M Honda, M Ito, T Watanabe, R Horie, N Yamamoto |
Cancer Science | 2005 |
Differential expression of NF-κB pathway genes among peripheral T-cell lymphomas
B Martínez-Delgado, M Cuadros, E Honrado, AR de la Parte, G Roncador, J Alves, JM Castrillo, C Rivas, J Benítez |
Leukemia | 2005 |
Pathologie des Hodgkin-Lymphoms
K Willenbrock, C Renné, A Bräuninger, ML Hansmann |
Der Onkologe | 2005 |
Germline mutations and polymorphisms in theNFKBIA gene in Hodgkin lymphoma
J Osborne, A Lake, FE Alexander, GM Taylor, RF Jarrett |
International Journal of Cancer | 2005 |
Grundlagen der molekularen Diagnostik und Therapie maligner Tumoren
PT Daniel, B Dörken |
Der Internist | 2005 |
Large B-cell lymphoma with Hodgkin's features
JF Garcia, M Mollejo, M Fraga, J Forteza, JA Muniesa, M Perez-Guillermo, C Perez-Seoane, T Rivera, P Ortega, MA Piris |
Histopathology | 2005 |
Glycoprotein Isolated fromSolanum nigrumL. Modulates the Apoptotic-Related Signals in 12-O-Tetradecanoylphorbol 13-Acetate-Stimulated MCF-7 Cells
KS Heo, KT Lim |
Journal of Medicinal Food | 2005 |
Expression of the tumor necrosis factor receptor—associated factors 1 and 2 and regulation of the nuclear factor—kB antiapoptotic activity in human gliomas
A Conti, MH Aguennouz, DL Torre, S Cardali, FF Angileri, C Buemi, C Tomasello, DG Iacopino, D D'Avella, G Vita, F Tomasello |
Journal of Neurosurgery | 2005 |
The Hodgkin and Reed/Sternberg cell
R Küppers, ML Hansmann |
The International Journal of Biochemistry & Cell Biology | 2005 |
Glycoprotein Isolated fromSolanum nigrumL. Kills HT-29 Cells Through Apoptosis
KT Lim |
Journal of Medicinal Food | 2005 |
Inhibition of NF-κB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines
MG García, L Alaniz, EC Lopes, G Blanco, SE Hajos, E Alvarez |
Leukemia Research | 2005 |
Chemosensitization and Radiosensitization of Tumors by Plant Polyphenols
AK Garg, TA Buchholz, BB Aggarwal |
Antioxidants & Redox Signaling | 2005 |
Immunosuppression by Combined Use of Cyclosporine and Resveratrol in a Rat Liver Transplantation Model
SL Wu, CE Pan, L Yu, KW Meng |
Transplantation Proceedings | 2005 |
Resveratrol prolongs allograft survival after liver transplantation in rats
SL Wu |
World journal of gastroenterology : WJG | 2005 |
Impact of Latent Epstein-Barr Virus Infection on Outcome in Children and Adolescents With Hodgkin's Lymphoma
A Claviez, M Tiemann, H Lüders, M Krams, R Parwaresch, G Schellong, W Dörffel |
Journal of Clinical Oncology | 2005 |
NFκB-dependent Down-regulation of Tumor Necrosis Factor Receptor-associated Proteins Contributes to Interleukin-1-mediated Enhancement of Ultraviolet B-induced Apoptosis
B Pöppelmann, K Klimmek, E Strozyk, R Voss, T Schwarz, D Kulms |
The Journal of biological chemistry | 2005 |
Fucoidan Extracted From Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells
K Haneji, T Matsuda, M Tomita, H Kawakami, K Ohshiro, JN Uchihara, M Masuda, N Takasu, Y Tanaka, T Ohta, N Mori |
Nutrition and Cancer | 2005 |
Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases
M Los, SB Gibson |
2005 | |
15-Deoxy-Δ12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-κB activity and down-regulation of antiapoptotic proteins
R Piva, P Gianferretti, A Ciucci, R Taulli, G Belardo, MG Santoro |
Blood | 2005 |
From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential
D Re, RK Thomas, K Behringer, V Diehl |
Blood | 2005 |
Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas
S Mathas, K Jöhrens, S Joos, A Lietz, F Hummel, M Janz, F Jundt, I Anagnostopoulos, K Bommert, P Lichter, H Stein, C Scheidereit, B Dörken |
Blood | 2005 |
Activation of Src kinase Lyn by the Kaposi sarcoma–associated herpesvirus K1 protein: implications for lymphomagenesis
O Prakash, OR Swamy, X Peng, ZY Tang, L Li, JE Larson, JC Cohen, J Gill, G Farr, S Wang, F Samaniego |
Blood | 2005 |
[Basics of molecular diagnostics and therapy of malignant tumors].
Daniel PT, Dörken B |
Der Internist | 2005 |
Resveratrol prolongs allograft survival after liver transplantation in rats.
Wu SL, Yu L, Meng KW, Ma ZH, Pan CE |
World Journal of Gastroenterology | 2005 |
Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor‐κB activity in unconditioned NOD/SCID/γcnull mice
Dewan MZ, Watanabe M, Ahmed S, Terashima K, Horiuchi S, Sata T, Honda M, Ito M, Watanabe T, Horie R, Yamamoto N |
Cancer Science | 2005 |
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
Margit A. Huber, Ninel Azoitei, Bernd Baumann, Stefan Grünert, Andreas Sommer, Hubert Pehamberger, Norbert Kraut, Hartmut Beug, Thomas Wirth |
Journal of Clinical Investigation | 2004 |
Aspirin and the Risk of Hodgkin's Lymphoma in a Population-Based Case-Control Study
ET Chang, T Zheng, EG Weir, M Borowitz, RB Mann, D Spiegelman, NE Mueller |
JNCI Journal of the National Cancer Institute | 2004 |
Bystander Cells and Prognosis in Hodgkin Lymphoma
D Molin |
Upsala Journal of Medical Sciences | 2004 |
Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death
A Dutton, JD O'Neil, AE Milner, GM Reynolds, J Starczynski, J Crocker, LS Young, PG Murray |
Proceedings of the National Academy of Sciences | 2004 |
Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells
N Mori, T Matsuda, M Tadano, T Kinjo, Y Yamada, K Tsukasaki, S Ikeda, Y Yamasaki, Y Tanaka, T Ohta, T Iwamasa, M Tomonaga, N Yamamoto |
Journal of virology | 2004 |
Epstein-Barr virus-associated Hodgkin's lymphoma
MK Gandhi, JT Tellam, R Khanna |
British Journal of Haematology | 2004 |
Part I: Hodgkin's lymphoma—molecular biology of Hodgkin and Reed-Sternberg cells
RK Thomas, D Re, J Wolf, V Diehl |
The Lancet Oncology | 2004 |
L-ascorbic acid represses constitutive activation of NF-?B and COX-2 expression in human acute myeloid leukemia, HL-60
SS Han, K Kim, ER Hahm, SJ Lee, YJ Surh, HK Park, WS Kim, CW Jung, MH Lee, K Park, JH Yang, SS Yoon, NH Riordan, HD Riordan, BF Kimler, CH Park, JH Lee, S Park |
Journal of Cellular Biochemistry | 2004 |
Nuclear factor-KappaB modulation as a therapeutic approach in hematologic malignancies
A Panwalkar, S Verstovsek, F Giles |
Cancer | 2004 |
Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed–Sternberg cells
M Bai, E Tsanou, NJ Agnantis, S Kamina, C Grepi, K Stefanaki, D Rontogianni, V Galani, P Kanavaros |
Modern Pathology | 2004 |
Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFκB transcription factors
M Sánchez-Beato, E Sánchez, JF García, A Pérez-Rosado, MC Montoya, M Fraga, MJ Artiga, M Navarrete, V Abraira, M Morente, M Esteller, H Koseki, M Vidal, MA Piris |
The Journal of Pathology | 2004 |
A 150-kDa glycoprotein isolated from Solanum nigrum L. has cytotoxic and apoptotic effects by inhibiting the effects of protein kinase C alpha, nuclear factor-kappa B and inducible nitric oxide in HCT-116 cells
SJ Lee, PS Oh, JH Ko, K Lim, KT Lim |
Cancer Chemotherapy and Pharmacology | 2004 |
In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2
LL Kis, J Nishikawa, M Takahara, N Nagy, L Matskova, K Takada, PG Elmberger, A Ohlsson, G Klein, E Klein |
International Journal of Cancer | 2004 |
Mutational analysis of the IkappaBalpha gene in activated B cell-like diffuse large B-cell lymphoma
RK Thomas, C Wickenhauser, S Tawadros, V Diehl, R Kuppers, J Wolf, R Schmitz |
British Journal of Haematology | 2004 |
Differential Expression Patterns of c-REL Protein in Classic and Nodular Lymphocyte Predominant Hodgkin Lymphoma
Q Xiao, N Shen, CV Hedvat, CH Moskowitz, LK Sussman, DA Filippa, AD Zelenetz, J Houldsworth, RS Chaganti, J Teruya-Feldstein |
Applied Immunohistochemistry & Molecular Morphology | 2004 |
A Beginner's Guide to NF-κB Signaling Pathways
S Delhalle, R Blasius, M Dicato, M Diederich |
Annals of the New York Academy of Sciences | 2004 |
Expression of constitutively active Nuclear-κB RelA transcription factor in blasts of acute myeloid leukemia
CE Bueso-Ramos, FC Rocha, S Shishodia, LJ Medeiros, HM Kantarjian, S Vadhan-Raj, Z Estrov, TL Smith, MH Nguyen, BB Aggarwal |
Human Pathology | 2004 |
Update on the Proteasome Inhibitor Bortezomibin Hematologic Malignancies
A Goy, F Gilles |
Clinical Lymphoma & Myeloma | 2004 |
Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells
F Morceau, A Duvoix, S Delhalle, M Schnekenburger, M Dicato, M Diederich |
Biochemical Pharmacology | 2004 |
Endostatin's Antiangiogenic Signaling Network
A Abdollahi, P Hahnfeldt, C Maercker, HJ Gröne, J Debus, W Ansorge, J Folkman, L Hlatky, PE Huber |
Molecular Cell | 2004 |
Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue
Liang-Liang Yu, Hong-Gang Yu, Jie-Ping Yu, He-Sheng Luo, Xi-Ming Xu, Jun-Hua Li |
World journal of gastroenterology : WJG | 2004 |
Nuclear factor-kB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue
LL Yu |
World journal of gastroenterology : WJG | 2004 |
c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis
S Mathas, A Lietz, I Anagnostopoulos, F Hummel, B Wiesner, M Janz, F Jundt, B Hirsch, K Jöhrens-Leder, HP Vornlocher, K Bommert, H Stein, B Dörken |
Journal of Experimental Medicine | 2004 |
A Cellular UDP-glucose Deficiency Causes Overexpression of Glucose/Oxygen-regulated Proteins Independent of the Endoplasmic Reticulum Stress Elements
M Flores-Diaz, JC Higuita, I Florin, T Okada, P Pollesello, T Bergman, M Thelestam, K Mori, A Alape-Giron |
The Journal of biological chemistry | 2004 |
Oncogenic and Anti-apoptotic Activity of NF-κB in Human Thyroid Carcinomas
F Pacifico, C Mauro, C Barone, E Crescenzi, S Mellone, M Monaco, G Chiappetta, G Terrazzano, D Liguoro, P Vito, E Consiglio, S Formisano, A Leonardi |
The Journal of biological chemistry | 2004 |
Considerations for Targeting Malignant Stem Cells in Leukemia
ML Guzman, CT Jordan |
Cancer control : journal of the Moffitt Cancer Center | 2004 |
Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas
J An, Y Sun, M Fisher, MB Rettig |
Leukemia | 2004 |
Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells
D Kumar, P Gokhale, C Broustas, D Chakravarty, I Ahmad, U Kasid |
Oncogene | 2004 |
NF-κB Family Proteins Participate in Multiple Steps of Hematopoiesis through Elimination of Reactive Oxygen Species
S Nakata, I Matsumura, H Tanaka, S Ezoe, Y Satoh, J Ishikawa, T Era, Y Kanakura |
The Journal of biological chemistry | 2004 |
Sensitization of Taxol-induced Apoptosis by Curcumin Involves Down-regulation of Nuclear Factor-κB and the Serine/Threonine Kinase Akt and Is Independent of Tubulin Polymerization
SV Bava, VT Puliappadamba, A Deepti, A Nair, D Karunagaran, RJ Anto |
The Journal of biological chemistry | 2004 |
Identification and Characterization of the IKKα Promoter: POSITIVE AND NEGATIVE REGULATION BY ETS-1 AND p53, RESPECTIVELY
L Gu, N Zhu, HW Findley, WG Woods, M Zhou |
The Journal of biological chemistry | 2004 |
Tumor necrosis factor α sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-κB
K Schmelz, T Wieder, I Tamm, A Müller, F Essmann, CC Geilen, K Schulze-Osthoff, B Dörken, PT Daniel |
Oncogene | 2004 |
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
S Mabuchi, M Ohmichi, Y Nishio, T Hayasaka, A Kimura, T Ohta, M Saito, J Kawagoe, K Takahashi, N Yada-Hashimoto, M Sakata, T Motoyama, H Kurachi, K Tasaka, Y Murata |
The Journal of biological chemistry | 2004 |
Hematopathology in Oncology
WG Finn, LA Peterson |
2004 | |
Cancer Immunotherapy at the Crossroads
JH Finke, RM Bukowski |
2004 | |
Molecular Signatures of Lymphoma
KJ Savage, RD Gascoyne |
International Journal of Hematology | 2004 |
Signal Transduction in Cancer
DA Frank |
2004 | |
Molecular Targeting and Signal Transduction
R Kumar |
2004 | |
Regulation of Constitutive p50/c-Rel Activity via Proteasome Inhibitor-Resistant IκBα Degradation in B Cells
S O'Connor, SD Shumway, IJ Amanna, CE Hayes, S Miyamoto |
Molecular and cellular biology | 2004 |
Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors
B Zheng, GV Georgakis, Y Li, A Bharti, D McConkey, BB Aggarwal, A Younes |
Clinical cancer research | 2004 |
Tumor Stroma Interactions Induce Chemoresistance in Pancreatic Ductal Carcinoma Cells Involving Increased Secretion and Paracrine Effects of Nitric Oxide and Interleukin-1β
S Müerköster, K Wegehenkel, A Arlt, M Witt, B Sipos, ML Kruse, T Sebens, G Klöppel, H Kalthoff, UR Fölsch, H Schäfer |
Cancer research | 2004 |
Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling
Ralf Küppers, Ulf Klein, Ines Schwering, Verena Distler, Andreas Bräuninger, Giorgio Cattoretti, Yuhai Tu, Gustavo A. Stolovitzky, Andrea Califano, Martin-Leo Hansmann, Riccardo Dalla-Favera |
Journal of Clinical Investigation | 2003 |
NF-kappaB and virus infection: who controls whom
MG Santoro, A Rossi, C Amici |
The EMBO Journal | 2003 |
Jesterone Dimer, a Synthetic Derivative of the Fungal Metabolite Jesterone, Blocks Activation of Transcription Factor Nuclear Factor κB by Inhibiting the Inhibitor of κB Kinase
MC Liang, S Bardhan, C Li, EA Pace, JA Porco, TD Gilmore |
Molecular pharmacology | 2003 |
Mutant human cells with constitutive activation of NF-kappaB
SS Sathe, N Sizemore, X Li, K Vithalani, M Commane, SM Swiatkowski, GR Stark |
Proceedings of the National Academy of Sciences | 2003 |
Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis
S Mathas, A Lietz, M Janz, M Hinz, F Jundt, C Scheidereit, K Bommert, B Dörken |
Blood | 2003 |
Inhibition of Constitutive NF-κB Activation in Mantle Cell Lymphoma B Cells Leads to Induction of Cell Cycle Arrest and Apoptosis
LV Pham, AT Tamayo, LC Yoshimura, P Lo, RJ Ford |
Journal of immunology (Baltimore, Md. : 1950) | 2003 |
Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-kappaB activity
C Cherbonnier, O Déas, G Carvalho, G Vassal, A Dürrbach, A Haeffner, B Charpentier, J Bénard, F Hirsch |
British Journal of Cancer | 2003 |
Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma
T Portis, P Dyck, R Longnecker |
Blood | 2003 |
Multiple effects of α1-antitrypsin on breast carcinoma MDA-MB 468 cell growth and invasiveness
I Zelvyte, S Lindgren, S Janciauskiene |
European Journal of Cancer Prevention | 2003 |
Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile
RG Jenner, K Maillard, N Cattini, RA Weiss, C Boshoff, R Wooster, P Kellam |
Proceedings of the National Academy of Sciences | 2003 |
AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells
M Watanabe, Y Ogawa, K Ito, M Higashihara, ME Kadin, LJ Abraham, T Watanabe, R Horie |
The American Journal of Pathology | 2003 |
Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes
I Schwering, A Bräuninger, V Distler, J Jesdinsky, V Diehl, ML Hansmann, K Rajewsky, R Küppers |
Molecular Medicine | 2003 |
Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma
G Siegler, E Kremmer, R Gonnella, G Niedobitek |
Molecular pathology : MP | 2003 |
NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach
S Amit, Y Ben-Neriah |
Seminars in Cancer Biology | 2003 |
Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-κB activation and tumor promotion
YS Keum, SS Han, KS Chun, KK Park, JH Park, SK Lee, YJ Surh |
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis | 2003 |
Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation
H D�rkop, B Hirsch, C Hahn, HD Foss, H Stein |
The Journal of Pathology | 2003 |
Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells
F Emmerich, S Theurich, M Hummel, A Haeffker, MS Vry, K D�hner, K Bommert, H Stein, B D�rken |
The Journal of Pathology | 2003 |
High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1
A Tzankov, A Zimpfer, A Lugli, J Krugmann, P Went, P Schraml, R Maurer, S Ascani, S Pileri, S Geley, S Dirnhofer |
The Journal of Pathology | 2003 |
Hodgkin disease immunopathogenesis: long-standing questions, recent answers, further directions
T Papadaki, K Stamatopoulos |
Trends in Immunology | 2003 |
The Molecular Basis for the Generation of Hodgkin and Reed-Sternberg Cells in Hodgkin’s Lymphoma
IS Lee, SH Kim, HG Song, SH Park |
International Journal of Hematology | 2003 |
Hodgkin’s Lymphoma and CD30 Signal Transduction
R Horie, M Higashihara, T Watanabe |
International Journal of Hematology | 2003 |
NF-κB in cancer: a marked target
A Lin, M Karin |
Seminars in Cancer Biology | 2003 |
Evolution of classic Hodgkin lymphoma in correlation to changes in the lymphoid organ structure of vertebrates
V Seitz, M Hummel, J Walter, H Stein |
Developmental & Comparative Immunology | 2003 |
Death receptor-induced cell death in prostate cancer
NV Guseva, AF Taghiyev, OW Rokhlin, MB Cohen |
Journal of Cellular Biochemistry | 2003 |
Nuclear Transcription Factor-kappaB in Hodgkin's Disease
A Younes, A Garg, BB Aggarwal |
Leukemia & Lymphoma | 2003 |
Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells
PY Yeh, SE Chuang, KH Yeh, YC Song, AL Cheng |
Biochemical Pharmacology | 2003 |
Viral Infections and Treatment: Pathogenesis and Treatment
N Raab-Traub, S Kenney |
Viral Infections and Treatment: Pathogenesis and Treatment | 2003 |
Overcoming Drug Resistance in Multiple Myeloma: The Emergence of Therapeutic Approaches to Induce Apoptosis
HH Yang, MH Ma, RA Vescio, JR Berenson |
Journal of Clinical Oncology | 2003 |
NF-κB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors
MC Turco, MF Romano, A Petrella, R Bisogni, P Tassone, S Venuta |
Leukemia | 2003 |
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
J Kucharczak, MJ Simmons, Y Fan, C Gélinas |
Oncogene | 2003 |
Phosphorylation of PPAR? via active ERK1/2 leads to its physical association with p65 and inhibition of NF-??
F Chen, M Wang, JP O'Connor, M He, T Tripathi, LE Harrison |
Journal of Cellular Biochemistry | 2003 |
Mitogenic and antiapoptotic role of constitutive NF-?B/Rel activity in pancreatic cancer
S Liptay, CK Weber, L Ludwig, M Wagner, G Adler, RM Schmid |
International Journal of Cancer | 2003 |
Senescence, apoptosis and therapy — cutting the lifelines of cancer
CA Schmitt |
Nature Reviews Cancer | 2003 |
Osteopontin Stimulates Cell Motility and Nuclear Factor κB-mediated Secretion of Urokinase Type Plasminogen Activator through Phosphatidylinositol 3-Kinase/Akt Signaling Pathways in Breast Cancer Cells
R Das, GH Mahabeleshwar, GC Kundu |
The Journal of biological chemistry | 2003 |
Divergent C-terminal transactivation domains of Rel/NF-κB proteins are critical determinants of their oncogenic potential in lymphocytes
Y Fan, B Rayet, C Gélinas |
Oncogene | 2003 |
NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells
M Bentires-Alj, V Barbu, M Fillet, A Chariot, B Relic, N Jacobs, J Gielen, MP Merville, V Bours |
Oncogene | 2003 |
NF-κB2/p100 induces Bcl-2 expression
P Viatour, M Bentires-Alj, A Chariot, V Deregowski, L Leval, MP Merville, V Bours |
Leukemia | 2003 |
NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4
G Helbig, KW Christopherson, P Bhat-Nakshatri, S Kumar, H Kishimoto, KD Miller, HE Broxmeyer, H Nakshatri |
The Journal of biological chemistry | 2003 |
PSK-mediated NF-κB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1
H Zhang, T Morisaki, C Nakahara, H Matsunaga, N Sato, F Nagumo, J Tadano, M Katano |
Oncogene | 2003 |
Epstein–Barr virus and oncogenesis: from latent genes to tumours
LS Young, PG Murray |
Oncogene | 2003 |
Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53
M Zhou, L Gu, N Zhu, WG Woods, HW Findley |
Oncogene | 2003 |
Molekularmedizinische Grundlagen von hämatologischen Neoplasien
D Ganten, K Ruckpaul, B Schlegelberger, C Fonatsch |
2003 | |
Profiling of Hodgkin’s Lymphoma Cell Line L1236 and Germinal Center B Cells: Identification of Hodgkin’s Lymphoma-specific Genes
I Schwering, A Bräuninger, V Distler, J Jesdinsky, V Diehl, ML Hansmann, K Rajewsky, R Küppers |
Molecular Medicine | 2003 |
Nuclear Factor кB
R Beyaert |
2003 | |
Mechanisms in Carcinogenesis and Cancer Prevention
HU Vainio, EK Hietanen |
2003 | |
Latent Membrane Protein 1, Tumor Necrosis Factor Receptor–Associated Factor (TRAF) 1, TRAF-2, TRAF-3, and Nuclear Factor Kappa B Expression in Posttransplantation Lymphoproliferative Disorders
P Ramalingam, WS Chu, R Tubbs, L Rybicki, J Pettay, ED Hsi |
Archives of pathology & laboratory medicine | 2003 |
Lysyl Oxidase Inhibits Ras-Mediated Transformation by Preventing Activation of NF-κB
S Jeay, S Pianetti, HM Kagan, GE Sonenshein |
Molecular and cellular biology | 2003 |
Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma
TF Barth, JI Martin-Subero, S Joos, CK Menz, C Hasel, G Mechtersheimer, RM Parwaresch, P Lichter, R Siebert, P Möller |
Blood | 2003 |
Hodgkin's lymphoma and CD30 signal transduction.
Horie R, Higashihara M, Watanabe T |
International Journal of Hematology | 2003 |
The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma.
Lee IS, Kim SH, Song HG, Park SH |
International Journal of Hematology | 2003 |
Nuclear Factor κB–dependent Gene Expression Profiling of Hodgkin's Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity
M Hinz, P Lemke, I Anagnostopoulos, C Hacker, D Krappmann, S Mathas, B Dörken, M Zenke, H Stein, C Scheidereit |
Journal of Experimental Medicine | 2002 |
Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B
S Mathas, M Hinz, I Anagnostopoulos, D Krappmann, A Lietz, F Jundt, K Bommert, F Mechta-Grigoriou, H Stein, B Dörken, C Scheidereit |
The EMBO Journal | 2002 |
Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells
R Horie, T Watanabe, K Ito, Y Morisita, M Watanabe, T Ishida, M Higashihara, M Kadin, T Watanabe |
The American Journal of Pathology | 2002 |
Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells
RK Thomas, A Kallenborn, C Wickenhauser, JL Schultze, A Draube, M Vockerodt, D Re, V Diehl, J Wolf |
The American Journal of Pathology | 2002 |
Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease
GM Reynolds, LJ Billingham, LJ Gray, JR Flavell, S Najafipour, J Crocker, P Nelson, LS Young, PG Murray |
British Journal of Haematology | 2002 |
NF-κB as a therapeutic target in cancer
RZ Orlowski, AS Baldwin |
Trends in Molecular Medicine | 2002 |
Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways
S Jeay, GE Sonenshein, MC Postel-Vinay, PA Kelly, E Baixeras |
Molecular and Cellular Endocrinology | 2002 |
Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer
T Gilmore, ME Gapuzan, D Kalaitzidis, D Starczynowski |
Cancer Letters | 2002 |
Antitumor Mechanisms of Oligodeoxynucleotides with CpG and PolyG Motifs in Murine Prostate Cancer Cells: Decrease of NF-κB and AP-1 Binding Activities and Induction of Apoptosis
W Shen, M Waldschmidt, X Zhao, T Ratliff, AM Krieg |
Antisense and Nucleic Acid Drug Development | 2002 |
Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review
YJ Surh |
Food and Chemical Toxicology | 2002 |
NF-kappaB in cancer: from innocent bystander to major culprit
M Karin, Y Cao, FR Greten, ZW Li |
Nature Reviews Cancer | 2002 |
Anticancer Drug Development
E Solary, N Droin, O Sordet, C Rebe, R Filomenko, A Wotawa, S Plenchette, P Ducoroy |
Anticancer Drug Development | 2002 |
Nuclear factor-kappa B and cancer: its role in prevention and therapy
AC Bharti, BB Aggarwal |
Biochemical Pharmacology | 2002 |
TNF-α Protects Human Primary Articular Chondrocytes from Nitric Oxide-Induced Apoptosis Via Nuclear Factor-κB
B Relić, M Bentires-Alj, C Ribbens, N Franchimont, PA Guerne, V Benoît, MP Merville, V Bours, MG Malaise |
Laboratory Investigation | 2002 |
Identification of cytokine-induced nuclear factor-kappaB target genes in ovarian and breast cancer cells
V Deregowski, S Delhalle, V Benoit, V Bours, MP Merville |
Biochemical Pharmacology | 2002 |
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-κB (NF-κB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells
SE Chuang, PY Yeh, YS Lu, GM Lai, CM Liao, M Gao, AL Cheng |
Biochemical Pharmacology | 2002 |
Stable Inhibition of NF-κB in Salivary Gland Cells Does Not Enhance Sensitivity to TNF-α-Induced Apoptosis Due to Upregulation of TRAF-1 Expression
K Aota, M Azuma, T Tamatani, T Yamashita, Y Ashida, M Sato |
Experimental Cell Research | 2002 |
Focus on lymphomas
LM Staudt, WH Wilson |
Cancer Cell | 2002 |
A CD40 Signalosome Anchored in Lipid Rafts Leads to Constitutive Activation of NF-κB and Autonomous Cell Growth in B Cell Lymphomas
LV Pham, AT Tamayo, LC Yoshimura, P Lo, N Terry, PS Reid, RJ Ford |
Immunity | 2002 |
Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2: Aberrations in Hodgkin's Lymphoma Cell Lines
S Joos, M Granzow, H Holtgreve-Grez, R Siebert, L Harder, JI Martín-Subero, J Wolf, M Adamowicz, TF Barth, P Lichter, A Jauch |
International Journal of Cancer | 2002 |
Identification of signal transduction pathways involved in constitutive NF-κB activation in breast cancer cells
P Bhat-Nakshatri, CJ Sweeney, H Nakshatri |
Oncogene | 2002 |
An NAD(P)H oxidase regulates growth and transcription in melanoma cells
SS Brar, TP Kennedy, AB Sturrock, TP Huecksteadt, MT Quinn, AR Whorton, JR Hoidal |
American journal of physiology. Cell physiology | 2002 |
Nuclear transcription factor-κB as a target for cancer drug development
A Garg, BB Aggarwal |
Leukemia | 2002 |
Increased IκB kinase activity is associated with activated NF-κB in acute myeloid blasts
B Baumgartner, M Weber, M Quirling, C Fischer, S Page, M Adam, C von Schilling, C Waterhouse, C Schmid, D Neumeier, K Brand |
Leukemia | 2002 |
Unique molecular and cellular features of acute myelogenous leukemia stem cells
CT Jordan |
Leukemia | 2002 |
Silibinin inhibits constitutive and TNFα-induced activation of NF-κB and sensitizes human prostate carcinoma DU145 cells to TNFα-induced apoptosis
S Dhanalakshmi, RP Singh, C Agarwal, R Agarwal |
Oncogene | 2002 |
Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical hodgkin lymphomas
EM Maggio, AV Berg, L Visser, A Diepstra, J Kluiver, R Emmens, S Poppema |
International Journal of Cancer | 2002 |
Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin–Reed-Sternberg cells
R Horie, T Watanabe, Y Morishita, K Ito, T Ishida, Y Kanegae, I Saito, M Higashihara, S Mori, ME Kadin, T Watanabe |
Oncogene | 2002 |
VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line
Tatsuya Asai, Yasuhiko Tomita, Shin-ichi Nakatsuka, Yoshihiko Hoshida, Akira Myoui, Hideki Yoshikawa, Katsuyuki Aozasa |
Japanese journal of cancer research : Gann | 2002 |
Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells
E Oelmann, H Herbst, M Zühlsdorf, O Albrecht, A Nolte, C Schmitmann, O Manzke, V Diehl, H Stein, WE Berdel |
Blood | 2002 |
The role of cytokines in classical Hodgkin lymphoma
BF Skinnider, TW Mak |
Blood | 2002 |
Biology of Hodgkin's lymphoma
R Küppers, I Schwering, A Bräuninger, K Rajewsky, ML Hansmann |
Annals of Oncology | 2002 |
High numbers of active caspase 3–positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcome
DF Dukers, CJ Meijer, RL ten Berge, W Vos, GJ Ossenkoppele, JJ Oudejans |
Blood | 2002 |
Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma
F Jundt, I Anagnostopoulos, R Förster, S Mathas, H Stein, B Dörken |
Blood | 2002 |
Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2
S Joos, CK Menz, G Wrobel, R Siebert, S Gesk, S Ohl, G Mechtersheimer, L Trümper, P Möller, P Lichter, TF Barth |
Blood | 2002 |
Fas Resistance of Leukemic Eosinophils Is Due to Activation of NF-κB by Fas Ligation
Y Qin, B Camoretti-Mercado, L Blokh, CG Long, FD Ko, KJ Hamann |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
VCP (p97) Regulates NFKB Signaling Pathway, Which Is Important for Metastasis of Osteosarcoma Cell Line
Asai T, Tomita Y, Nakatsuka S, Hoshida Y, Myoui A, Yoshikawa H, Aozasa K |
Japanese journal of cancer research : Gann | 2002 |
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kB
Albert Baldwin |
Journal of Clinical Investigation | 2001 |
Antiproliferative Effects of IFN-αCorrelate with the Downregulation of Nuclear Factor-κB in Human Burkitt Lymphoma Daudi Cells
PC Rath, BB Aggarwal |
Journal of Interferon & Cytokine Research | 2001 |
relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells
A Ricca, A Biroccio, D Trisciuoglio, M Cippitelli, G Zupi, DD Bufalo |
British Journal of Cancer | 2001 |
Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways
CA Fielding, K Sandvej, A Mehl, P Brennan, M Jones, M Rowe |
Journal of virology | 2001 |
Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236
A Staratschek-Jox, RK Thomas, T Zander, N Massoudi, M Kornacker, J Bullerdiek, C Fonatsch, V Diehl, J Wolf |
British Journal of Cancer | 2001 |
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation
YJ Surh, KS Chun, HH Cha, SS Han, YS Keum, KK Park, SS Lee |
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis | 2001 |
High expression levels of nuclear factor ?B, I?B kinase ? and Akt kinase in squamous cell carcinoma of the oral cavity
H Nakayama, T Ikebe, M Beppu, K Shirasuna |
Cancer | 2001 |
Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's disease
PG Murray, JR Flavell, KR Baumforth, SM Toomey, D Lowe, J Crocker, RF Ambinder, LS Young |
The Journal of Pathology | 2001 |
The Reed-Sternberg cell in classical Hodgkin's disease
WC Chan |
Hematological Oncology | 2001 |
Analysis of expression of nuclear factor kappaB (NF-kappaB) in multiple myeloma: downregulation of NF-kappaB induces apoptosis
H Ni, M Ergin, Q Huang, JZ Qin, HM Amin, RL Martinez, S Saeed, K Barton, S Alkan |
British Journal of Haematology | 2001 |
Gingival Overgrowth as the Initial Paraneoplastic Manifestation of Hodgkin's Lymphoma in a Child. A Case Report
O Nicolatou-Galitis, T Papadaki, M Moshovi, JJ Kamma, CV Vliet-Constantinidou, C Tsoumakas, A Kattamis, F Tzortzatou-Stathopoulou |
Journal of Periodontology | 2001 |
Capsaicin suppresses phorbol ester-induced activation of NF-κB/Rel and AP-1 transcription factors in mouse epidermis
SS Han, YS Keum, HJ Seo, KS Chun, SS Lee, YJ Surh |
Cancer Letters | 2001 |
IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development
Y Cao, G Bonizzi, TN Seagroves, FR Greten, R Johnson, EV Schmidt, M Karin |
Cell | 2001 |
Ubiquitin proteasome pathway: implications and advances in cancer therapy
SA Shah, MW Potter, MP Callery |
Surgical Oncology | 2001 |
Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN
S Pianetti, M Arsura, R Romieu-Mourez, RJ Coffey, GE Sonenshein |
Oncogene | 2001 |
Nuclear factor-κB is upregulated in colorectal cancer
DS Lind, SN Hochwald, J Malaty, S Rekkas, P Hebig, G Mishra, LL Moldawer, EM Copeland, S MacKay |
Surgery | 2001 |
Involvement of nuclear factor-kappa B (NF-κB) activation in mitogen-induced lymphocyte proliferation: inhibitory effects of lymphoproliferation by salicylates acting as NF-κB inhibitors
L Cavallini, MA Francesconi, F Zoccarato, A Alexandre |
Biochemical Pharmacology | 2001 |
Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production
X Gao, YX Xu, N Janakiraman, RA Chapman, SC Gautam∗ |
Biochemical Pharmacology | 2001 |
Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells
RE Davis, KD Brown, U Siebenlist, LM Staudt |
Journal of Experimental Medicine | 2001 |
Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-κB in malignant melanoma cells
SS Brar, TP Kennedy, AR Whorton, AB Sturrock, TP Huecksteadt, AJ Ghio, JR Hoidal |
American journal of physiology. Cell physiology | 2001 |
Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines
M Bentires-Alj, E Dejardin, P Viatour, CV Lint, B Froesch, JC Reed, MP Merville, V Bours |
Oncogene | 2001 |
Nuclear Factor-κB-inducible Death Effector Domain-containing Protein Suppresses Tumor Necrosis Factor-mediated Apoptosis by Inhibiting Caspase-8 Activity
Z You, H Ouyang, D Lopatin, PJ Polver, CY Wang |
The Journal of biological chemistry | 2001 |
Phosphatidylinositol 3-Kinase and NF-κB Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen Activator
D Sliva, MT Rizzo, D English |
The Journal of biological chemistry | 2001 |
High constitutive level of NF-κB is crucial for viability of adenocarcinoma cells
AS Smirnov, AS Ruzov, AV Budanov, AV Prokhortchouk, AV Ivanov, EB Prokhortchouk |
Cell Death and Differentiation | 2001 |
Characterization of NF-κB Expression in Hodgkin’s Disease: Inhibition of Constitutively Expressed NF-κB Results in Spontaneous Caspase-Independent Apoptosis in Hodgkin and Reed-Sternberg Cells
KF Izban, M Ergin, Q Huang, J Qin, RL Martinez, B Schnitzer, H Ni, BJ Nickoloff, S Alkan |
Modern Pathology | 2001 |
Murine embryonic fibroblasts lacking TC-PTP display delayed G1 phase through defective NF-κB activation
MJ Ibarra-Sánchez, J Wagner, MT Ong, C Lampron, ML Tremblay |
Oncogene | 2001 |
Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines
A Mukhopadhyay, C Bueso-Ramos, D Chatterjee, P Pantazis, BB Aggarwal |
Oncogene | 2001 |
Differential effects of Ras signaling through NFκB on skeletal myogenesis
N Mitin, AJ Kudla, SF Konieczny, EJ Taparowsky |
Oncogene | 2001 |
Epstein–Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFκB pathway
M Vockerodt, H Tesch, D Kube |
Genes and Immunity | 2001 |
Leukocyte Recruitment, Endothelial Cell Adhesion Molecules, and Transcriptional Control
T Collins |
2001 | |
Signaling pathways activated by daunorubicin
G Laurent, JP Jaffrézou |
Blood | 2001 |
STAT3 is constitutively activated in Hodgkin cell lines
D Kube, U Holtick, M Vockerodt, T Ahmadi, B Haier, I Behrmann, PC Heinrich, V Diehl, H Tesch |
Blood | 2001 |
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
ML Guzman, SJ Neering, D Upchurch, B Grimes, DS Howard, DA Rizzieri, SM Luger, CT Jordan |
Blood | 2001 |
CD99 expression is positively regulated by Sp1 and is negatively regulated by Epstein-Barr virus latent membrane protein 1 through nuclear factor-κB
I Lee, MK Kim, EY Choi, A Mehl, KC Jung, MC Gil, M Rowe, SH Park |
Blood | 2001 |
The Role of NF-κB in TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis of Melanoma Cells
AV Franco, XD Zhang, EV Berkel, JE Sanders, , WD Thomas, T Nguyen, P Hersey |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells
M Hinz, P Löser, S Mathas, D Krappmann, B Dörken, C Scheidereit |
Blood | 2001 |
The role of constitutive NF-kappaB activity in PC-3 human prostate cancer cell invasive behavior
P F Lindholm, J Bub, S Kaul, V B Shidham, A Kajdacsy-Balla |
Clinical & Experimental Metastasis | 2001 |
Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3
MA Sovak, RE Bellas, DW Kim, GJ Zanieski, AE Rogers, AM Traish, GE Sonenshein |
Journal of Clinical Investigation | 2000 |
Interaction between host T cells and Reed–Sternberg cells in Hodgkin lymphomas
S Poppema, A Berg |
Seminars in Cancer Biology | 2000 |
Kinase Inhibitors in Cancer Therapy
H Sedlacek |
Drugs | 2000 |
NF-κB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment
V Bours, G Bonizzi, M Bentires-Alj, F Bureau, J Piette, P Lekeux, MP Merville |
Toxicology | 2000 |
Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death
DC Duffey, CV Crowl-Bancroft, Z Chen, FG Ondrey, M Nejad-Sattari, G Dong, CV Waes |
British Journal of Cancer | 2000 |
The molecular and cellular origins of Hodgkin's disease
LM Staudt |
Journal of Experimental Medicine | 2000 |
Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells
M Arsura, F Mercurio, AL Oliver, SS Thorgeirsson, GE Sonenshein |
Molecular and cellular biology | 2000 |
Hodgkin's disease and the Epstein-Barr virus
KJ Flavell, PG Murray |
Molecular pathology : MP | 2000 |
Regulation of CD30 antigen expression and its potential significance for human disease
ME Kadin |
The American Journal of Pathology | 2000 |
Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma
B Jungnickel, A Staratschek-Jox, A Bräuninger, T Spieker, J Wolf, V Diehl, ML Hansmann, K Rajewsky, R Küppers |
Journal of Experimental Medicine | 2000 |
Dietary Anticarcinogens and Antimutagens
S Southon, R Faulks, A Fillery-Travis |
Dietary Anticarcinogens and Antimutagens | 2000 |
The Molecular and Cellular Origins of Hodgkin's Disease
LM Staudt |
Journal of Experimental Medicine | 2000 |
The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
MW Mayo, AS Baldwin |
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 2000 |
A high constitutive level of NF-κB is necessary for the viability of mouse adenocarcinoma cells: A possible role of p53
AS Smirnov, AV Budanov, AS Ruzov, AV Ivanov, AV Prokhorchuk, NV Gnuchev, EB Prokhorchuk |
Molecular Biology | 2000 |
Constitutive activation of nuclear factor ?B in hepatocellular carcinoma
DI Tai, SL Tsai, YH Chang, SN Huang, TC Chen, KS Chang, YF Liaw |
Cancer | 2000 |
Epstein-Barr virus and hodgkin’s disease
LM Weiss |
Current Oncology Reports | 2000 |
I?B?-related proteins in normal and transformed colonic epithelial cells
MS Inan, R Place, V Tolmacheva, QS Wang, AK Hubbard, DW Rosenberg, C Giardina |
Molecular Carcinogenesis | 2000 |
Distinct Effects of CD30 and Fas Signaling in Cutaneous Anaplastic Lymphomas: A Possible Mechanism for Disease Progression
E Levi, Z Wang, T Petrogiannis-Haliotis, WM Pfeifer, W Kempf, R Drews, ME Kadin |
Journal of Investigative Dermatology | 2000 |
Clonal Deleterious Mutations in the I b Gene in the Malignant Cells in Hodgkin's Lymphoma
B Jungnickel, A Staratschek-Jox, A Brauninger, T Spieker, J Wolf, V Diehl, ML Hansmann, K Rajewsky, R Kuppers |
Journal of Experimental Medicine | 2000 |
Apoptosis and radiosensitization of Hodgkin cells by proteasome inhibition
F Pajonk, K Pajonk, WH McBride |
International journal of radiation oncology, biology, physics | 2000 |
Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3
MA Sovak, RE Bellas, DW Kim, GJ Zanieski, AE Rogers, AM Traish, GE Sonenshein |
Oncogene | 2000 |
Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells
JC Cusack, R Liu, AS Baldwin |
Cancer research | 2000 |
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide
NM Patel, S Nozaki, NH Shortle, P Bhat-Nakshatri, TR Newton, S Rice, V Gelfanov, SH Boswell, RJ Goulet, GW Sledge, H Nakshatri |
Oncogene | 2000 |
Nuclear factor κB in proliferation, activation, and apoptosis in rat hepatic stellate cells
A Lang, R Schoonhoven, S Tuvia, DA Brenner, RA Rippe |
Journal of Hepatology | 2000 |
Adenovirus-mediated transfer of caspase-8 in combination with superrepressor of NF-kappaB drastically induced apoptosis in gliomas
N Shinoura, N Yamamoto, Y Yoshida, A Asai, T Kirino, H Hamada |
Biochemical and Biophysical Research Communications | 2000 |
Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells
RR Furman, Z Asgary, JO Mascarenhas, HC Liou, EJ Schattner |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
5-Fluorouracil induces apoptosis through the suppression of NF-kappaB activity in human salivary gland cancer cells
K Aota, M Azuma, T Yamashita, T Tamatani, K Motegi, N Ishimaru, Y Hayashi, M Sato |
Biochemical and Biophysical Research Communications | 2000 |
Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells
JC Cusack, R Liu, AS Baldwin |
Cancer research | 2000 |
Nuclear factor-κB, cancer, and apoptosis
V Bours, M Bentires-Alj, AC Hellin, P Viatour, P Robe, S Delhalle, V Benoit, MP Merville |
Biochemical Pharmacology | 2000 |
Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells
I Plo, D Lautier, T Levade, H Sekouri, JP Jaffrézou, G Laurent, A Bettaïeb |
Biochemical Journal | 2000 |
Hyaluronidase Induction of a WW Domain-containing Oxidoreductase That Enhances Tumor Necrosis Factor Cytotoxicity
NS Chang, N Pratt, J Heath, L Schultz, D Sleve, GB Carey, N Zevotek |
The Journal of biological chemistry | 2000 |
Transcription factor NF-κB participates in regulation of epithelial cell turnover in the colon
MS Inan, V Tolmacheva, QS Wang, DW Rosenberg, C Giardina |
AJP Gastrointestinal and Liver Physiology | 2000 |
Additive effect between NF-κB subunits and p53 protein for transcriptional activation of human p53 promoter
V Benoit, AC Hellin, S Huygen, J Gielen, V Bours, MP Merville |
Oncogene | 2000 |
Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-κB/Rel− specific decoy oligodeoxynucleotides
MF Romano, A Lamberti, R Bisogni, P Tassone, D Pagnini, G Storti, LD Vecchio, MC Turco, S Venuta |
Gene Therapy | 2000 |
Expression of the Tumor Necrosis Factor Receptor-Associated Factors (TRAFs) 1 and 2 is a Characteristic Feature of Hodgkin and Reed-Sternberg Cells
KF Izban, M Ergin, RL Martinez, S Alkan |
Modern Pathology | 2000 |
NF-κB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis
H Jo, R Zhang, H Zhang, TA McKinsey, J Shao, RD Beauchamp, DW Ballard, P Liang |
Oncogene | 2000 |
Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells
U Kordes, D Krappmann, V Heissmeyer, WD Ludwig, C Scheidereit |
Leukemia | 2000 |
Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies
E Solary, N Droin, A Bettaieb, L Corcos, MT Dimanche-Boitrel, C Garrido |
Leukemia | 2000 |
Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors
R von Wasielewski, S Seth, J Franklin, R Fischer, K Hübner, ML Hansmann, V Diehl, A Georgii |
Blood | 2000 |
The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-x L
C Chen, LC Edelstein, C Gélinas |
Molecular and cellular biology | 2000 |
IFN-α Suppresses Activation of Nuclear Transcription Factors NF-κB and Activator Protein 1 and Potentiates TNF-Induced Apoptosis
SK Manna, A Mukhopadhyay, BB Aggarwal |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells
SS Mir, BW Richter, CS Duckett |
Blood | 2000 |
Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid
I Ponzanelli, M Giannı̀, R Giavazzi, A Garofalo, I Nicoletti, U Reichert, E Erba, A Rambaldi, M Terao, E Garattini |
Blood | 2000 |
Kinase Inhibitors in Cancer Therapy: A Look Ahead
H Sedlacek |
Drugs | 2000 |
Epstein-Barr virus and Hodgkin's disease.
Weiss LM |
Current Oncology Reports | 2000 |
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
DC Guttridge, C Albanese, JY Reuther, RG Pestell, AS Baldwin |
Molecular and cellular biology | 1999 |
Recent advances in the molecular pathogenesis of lymphomas
A Sarris, R Ford |
Current Opinion in Oncology | 1999 |
Genistein Inhibits Constitutive and Inducible NFκB Activation and Decreases IL-8 Production by Human Cystic Fibrosis Bronchial Gland Cells
O Tabary, S Escotte, JP Couetil, D Hubert, D Dusser, E Puchelle, J Jacquot |
The American Journal of Pathology | 1999 |
Genistein inhibits constitutive and inducible NFkappaB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells
O Tabary, S Escotte, JP Couetil, D Hubert, D Dusser, E Puchelle, J Jacquot |
The American Journal of Pathology | 1999 |
NF-κB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications
N Arima, K Matsushita, H Obata, H Ohtsubo, H Fujiwara, K Arimura, T Kukita, Y Suruga, S Wakamatsu, S Hidaka, C Tei |
Experimental Hematology | 1999 |
Apoptosis and HIV infection: T-cells fiddle while the immune system burns
B Goldberg, RB Stricker |
Immunology Letters | 1999 |
Iκβα Is Essential for Maintaining Basal c-Jun N-Terminal Kinase (JNK) Activation and Regulating JNK-Mediated Resistance to Tumor Necrosis Factor Cytotoxicity in L929 Cells
NS Chang |
Biochemical and Biophysical Research Communications | 1999 |
NF- κ B and chemoresistance: could NF- κ B be an antitumor target?
M Bentires-Alj, MP Merville, V Bours |
Drug Resistance Updates | 1999 |
New insights into the roles of ReL/NF-κB transcription factors in immune function, hemopoiesis and human disease
M Grossmann, Y Nakamura, R Grumont, S Gerondakis |
The International Journal of Biochemistry & Cell Biology | 1999 |
The NF-κB/Rel family of transcription factors in oncogenic transformation and apoptosis
R Martin, JA Schmid, R Hofer-Warbinek |
Mutation Research/Reviews in Mutation Research | 1999 |
9-Nitrocamptothecin Selectively Inhibits Human Immunodeficiency Virus Type 1 Replication in Freshly Infected Parental but Not 9-Nitrocamptothecin-Resistant U937 Monocytoid Cells
MR Sadaie, J Doniger, CL Hung, P Pantazis |
AIDS Research and Human Retroviruses | 1999 |
Transcription Factors in Lymphocyte Development— T and B Cells Get Together
LH Glimcher, H Singh |
Cell | 1999 |
Paediatric Hodgkin's disease
R Pötter |
European Journal of Cancer | 1999 |
Aberrant rel/nfkb genes and activity in human cancer
B Rayet, C Gélinas |
Oncogene | 1999 |
Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha
H Ishikawa, D Carrasco, E Claudio, RP Ryseck, R Bravo |
Oncogene | 1999 |
Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha
H Ishikawa, D Carrasco, E Claudio, RP Ryseck, R Bravo |
Oncogene | 1999 |
NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species
C Giardina, H Boulares, M S Inan |
Biochimica et Biophysica Acta | 1999 |
How NF-κB is activated: the role of the IκB kinase (IKK) complex
M Karin |
Oncogene | 1999 |
The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation
M Karin |
The Journal of biological chemistry | 1999 |
Persistent activation of nuclear factor-?B in cultured rat hepatic stellate cells involves the induction of potentially novel rel-like factors and prolonged changes in the expression of I?B family proteins
AM Elsharkawy, MC Wright, RT Hay, MJ Arthur, T Hughes, MJ Bahr, K Degitz, DA Mann |
Hepatology | 1999 |
Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
D Krappmann, F Emmerich, U Kordes, E Scharschmidt, B Dörken, C Scheidereit |
Oncogene | 1999 |
Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators
B Kaltschmidt, C Kaltschmidt, SP Hehner, W Dröge, ML Schmitz |
Oncogene | 1999 |
Negative Regulation of Transactivation Function but Not DNA Binding of NF-κB and AP-1 by IκBβ1 in Breast Cancer Cells
TR Newton, NM Patel, P Bhat-Nakshatri, CR Stauss, RJ Goulet, H Nakshatri |
The Journal of biological chemistry | 1999 |
Constitutive activation of transcription factors NF-?B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines
FG Ondrey, G Dong, J Sunwoo, Z Chen, JS Wolf, CV Crowl-Bancroft, N Mukaida, CV Waes |
Molecular Carcinogenesis | 1999 |
Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells
E Dejardin, V Deregowski, M Chapelier, N Jacobs, J Gielen, MP Merville, V Bours |
Oncogene | 1999 |
NF-κB as a primary regulator of the stress response
F Mercurio, AM Manning |
Oncogene | 1999 |
Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop
B Levkau, M Scatena, CM Giachelli, R Ross, EW Raines |
Nature Cell Biology | 1999 |
Integration of Rac-dependent Regulation of Cyclin D1 Transcription through a Nuclear Factor-κB-dependent Pathway
D Joyce, B Bouzahzah, M Fu, C Albanese, M DAmico, J Steer, JU Klein, RJ Lee, JE Segall, JK Westwick, CJ Der, RG Pestell |
The Journal of biological chemistry | 1999 |
Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease
H Knecht, C Berger, C McQuain, S Rothenberger, E Bachmann, J Martin, C Esslinger, HG Drexler, YC Cai, PJ Quesenberry, BF Odermatt |
Oncogene | 1999 |
NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G 0 /G 1 -to-S-Phase Transition
M Hinz, D Krappmann, A Eichten, A Heder, C Scheidereit, M Strauss |
Molecular and cellular biology | 1999 |
Role of NF-κB in the Rescue of Multiple Myeloma Cells From Glucocorticoid-Induced Apoptosis by Bcl-2
R Feinman, J Koury, M Thames, B Barlogie, J Epstein, DS Siegel |
Blood | 1999 |
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
DC Guttridge, C Albanese, JY Reuther, RG Pestell, AS Baldwin |
Molecular and cellular biology | 1999 |
Tumor Necrosis Factor Receptor-Associated Factor 1 Is Overexpressed in Reed-Sternberg Cells of Hodgkin’s Disease and Epstein-Barr Virus-Transformed Lymphoid Cells
H Dürkop, HD Foss, G Demel, H Klotzbach, C Hahn, H Stein |
Blood | 1999 |
CD30-CD30 Ligand Interaction in Primary Cutaneous CD30+T-Cell Lymphomas: A Clue to the Pathophysiology of Clinical Regression
M Mori, C Manuelli, N Pimpinelli, C Mavilia, E Maggi, M Santucci, B Bianchi, P Cappugi, B Giannotti, ME Kadin |
Blood | 1999 |
Overexpression of I Kappa B Alpha Without Inhibition of NF-κB Activity and Mutations in the I Kappa B Alpha Gene in Reed-Sternberg Cells
F Emmerich, M Meiser, M Hummel, G Demel, HD Foss, F Jundt, S Mathas, D Krappmann, C Scheidereit, H Stein, B Dörken |
Blood | 1999 |
Mutation of the p53 Gene Is Not a Typical Feature of Hodgkin and Reed-Sternberg Cells in Hodgkin’s Disease
M Montesinos-Rongen, A Roers, R Küppers, K Rajewsky, ML Hansmann |
Blood | 1999 |
Transcriptional Cross Talk between NF-κB and p53
GA Webster, ND Perkins |
Molecular and cellular biology | 1999 |
Transcriptional Cross Talk between NF-κB and p53
GA Webster, ND Perkins |
Molecular and cellular biology | 1999 |
Transcriptional cross talk between NF-kappaB and p53.
Webster GA, Perkins ND |
Molecular and cellular biology | 1999 |
Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells
E DiMango, AJ Ratner, R Bryan, S Tabibi, A Prince |
Journal of Clinical Investigation | 1998 |
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation
JY Reuther, GW Reuther, D Cortez, AM Pendergast, AS Baldwin |
Genes & development | 1998 |
Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues
J Irsch, S Nitsch, ML Hansmann, K Rajewsky, H Tesch, V Diehl, A Jox, R Küppers, A Radbruch |
Proceedings of the National Academy of Sciences | 1998 |
Chronic Antagonism of Nuclear Factor-κB Activity in Cytotrophoblasts by Dexamethasone: A Potential Mechanism for Antiinflammatory Action of Glucocorticoids in Human Placenta1
T Rosen, G Krikun, Y Ma, EY Wang, CJ Lockwood, S Guller |
The Journal of clinical endocrinology and metabolism | 1998 |
Clinically relevant findings
TD Gilmore |
Journal of Clinical Investigation | 1997 |